| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | extracellular matrix structural constituent conferring tensile strength | COL2A1 COL3A1 COL18A1 COL7A1 COL11A1 COL28A1 COL5A3 COL22A1 COL1A1 COL1A2 | 1.13e-17 | 46 | 49 | 10 | GO:0030020 |
| GeneOntologyMolecularFunction | extracellular matrix structural constituent | COL2A1 COL3A1 COL18A1 COL7A1 COL11A1 IGFBP7 COL28A1 COL5A3 COL22A1 COL1A1 COL1A2 | 8.19e-13 | 188 | 49 | 11 | GO:0005201 |
| GeneOntologyMolecularFunction | platelet-derived growth factor binding | 1.56e-08 | 12 | 49 | 4 | GO:0048407 | |
| GeneOntologyMolecularFunction | DNA-binding transcription factor activity, RNA polymerase II-specific | MSX1 FOXD3 CEBPA HOXD11 SAMD11 ESRRA SKOR2 BHLHE22 PITX1 ZBTB4 RFX6 ZNF579 PBX1 PHOX2B PBX2 TAL1 | 1.29e-07 | 1412 | 49 | 16 | GO:0000981 |
| GeneOntologyMolecularFunction | cis-regulatory region sequence-specific DNA binding | MSX1 FOXD3 CEBPA HOXD11 ESRRA SKOR2 BHLHE22 PITX1 ZBTB4 RFX6 PBX1 PHOX2B PBX2 TAL1 DNMT3A | 2.12e-07 | 1271 | 49 | 15 | GO:0000987 |
| GeneOntologyMolecularFunction | RNA polymerase II cis-regulatory region sequence-specific DNA binding | FOXD3 CEBPA HOXD11 ESRRA SKOR2 BHLHE22 PITX1 ZBTB4 RFX6 PBX1 PHOX2B PBX2 TAL1 DNMT3A | 1.06e-06 | 1244 | 49 | 14 | GO:0000978 |
| GeneOntologyMolecularFunction | RNA polymerase II transcription regulatory region sequence-specific DNA binding | MSX1 FOXD3 CEBPA HOXD11 ESRRA SKOR2 BHLHE22 PITX1 ZBTB4 RFX6 PBX1 PHOX2B PBX2 TAL1 DNMT3A | 1.23e-06 | 1459 | 49 | 15 | GO:0000977 |
| GeneOntologyMolecularFunction | structural molecule activity | COL2A1 COL3A1 COL18A1 COL7A1 COL11A1 IGFBP7 COL28A1 COL5A3 COL22A1 COL1A1 COL1A2 | 8.06e-06 | 891 | 49 | 11 | GO:0005198 |
| GeneOntologyMolecularFunction | growth factor binding | 3.94e-05 | 156 | 49 | 5 | GO:0019838 | |
| GeneOntologyMolecularFunction | DNA-binding transcription activator activity, RNA polymerase II-specific | 5.96e-05 | 560 | 49 | 8 | GO:0001228 | |
| GeneOntologyMolecularFunction | DNA-binding transcription activator activity | 6.42e-05 | 566 | 49 | 8 | GO:0001216 | |
| GeneOntologyMolecularFunction | chromatin binding | 6.75e-05 | 739 | 49 | 9 | GO:0003682 | |
| GeneOntologyMolecularFunction | unmethylated CpG binding | 2.62e-04 | 10 | 49 | 2 | GO:0045322 | |
| GeneOntologyMolecularFunction | DNA-binding transcription repressor activity, RNA polymerase II-specific | 1.10e-03 | 320 | 49 | 5 | GO:0001227 | |
| GeneOntologyMolecularFunction | DNA-binding transcription repressor activity | 1.19e-03 | 326 | 49 | 5 | GO:0001217 | |
| GeneOntologyMolecularFunction | SMAD binding | 1.23e-03 | 86 | 49 | 3 | GO:0046332 | |
| GeneOntologyMolecularFunction | DNA-binding transcription factor binding | 2.88e-03 | 582 | 49 | 6 | GO:0140297 | |
| GeneOntologyMolecularFunction | histone deacetylase binding | 5.62e-03 | 147 | 49 | 3 | GO:0042826 | |
| GeneOntologyBiologicalProcess | collagen fibril organization | 1.10e-11 | 76 | 50 | 8 | GO:0030199 | |
| GeneOntologyBiologicalProcess | skeletal system development | COL2A1 COL3A1 MSX1 COL18A1 COL11A1 HOXD11 ESRRA PITX1 HSD17B1 PBX1 COL1A1 COL1A2 | 1.91e-08 | 615 | 50 | 12 | GO:0001501 |
| GeneOntologyBiologicalProcess | extracellular matrix organization | COL2A1 COL3A1 COL18A1 COL7A1 COL11A1 COL28A1 COL5A3 COL22A1 COL1A1 COL1A2 | 1.98e-08 | 377 | 50 | 10 | GO:0030198 |
| GeneOntologyBiologicalProcess | extracellular structure organization | COL2A1 COL3A1 COL18A1 COL7A1 COL11A1 COL28A1 COL5A3 COL22A1 COL1A1 COL1A2 | 2.03e-08 | 378 | 50 | 10 | GO:0043062 |
| GeneOntologyBiologicalProcess | external encapsulating structure organization | COL2A1 COL3A1 COL18A1 COL7A1 COL11A1 COL28A1 COL5A3 COL22A1 COL1A1 COL1A2 | 2.08e-08 | 379 | 50 | 10 | GO:0045229 |
| GeneOntologyBiologicalProcess | cartilage development | 1.16e-07 | 243 | 50 | 8 | GO:0051216 | |
| GeneOntologyBiologicalProcess | connective tissue development | COL2A1 COL3A1 MSX1 COL11A1 HOXD11 ESRRA PITX1 HSD17B1 COL1A1 | 1.20e-07 | 343 | 50 | 9 | GO:0061448 |
| GeneOntologyBiologicalProcess | appendage morphogenesis | 3.01e-07 | 185 | 50 | 7 | GO:0035107 | |
| GeneOntologyBiologicalProcess | limb morphogenesis | 3.01e-07 | 185 | 50 | 7 | GO:0035108 | |
| GeneOntologyBiologicalProcess | embryonic organ development | COL2A1 MSX1 COL18A1 FOXD3 COL11A1 CEBPA HOXD11 PBX1 PBX2 TAL1 | 7.89e-07 | 561 | 50 | 10 | GO:0048568 |
| GeneOntologyBiologicalProcess | sensory organ development | COL2A1 MSX1 COL11A1 CEBPA IGFBP7 SAMD11 NTF4 BHLHE22 PBX1 PHOX2B PBX2 | 1.07e-06 | 730 | 50 | 11 | GO:0007423 |
| GeneOntologyBiologicalProcess | limb development | 1.09e-06 | 224 | 50 | 7 | GO:0060173 | |
| GeneOntologyBiologicalProcess | appendage development | 1.09e-06 | 224 | 50 | 7 | GO:0048736 | |
| GeneOntologyBiologicalProcess | animal organ morphogenesis | COL2A1 COL3A1 MSX1 COL18A1 COL11A1 HOXD11 SAMD11 NTF4 BHLHE22 PBX1 PBX2 COL1A1 COL1A2 | 7.11e-06 | 1269 | 50 | 13 | GO:0009887 |
| GeneOntologyBiologicalProcess | bone morphogenesis | 1.24e-05 | 124 | 50 | 5 | GO:0060349 | |
| GeneOntologyBiologicalProcess | embryo development | COL2A1 COL3A1 MSX1 COL18A1 FOXD3 COL11A1 CEBPA HOXD11 PITX1 PBX1 PBX2 TAL1 COL1A1 | 2.69e-05 | 1437 | 50 | 13 | GO:0009790 |
| GeneOntologyBiologicalProcess | embryonic limb morphogenesis | 2.90e-05 | 148 | 50 | 5 | GO:0030326 | |
| GeneOntologyBiologicalProcess | embryonic appendage morphogenesis | 2.90e-05 | 148 | 50 | 5 | GO:0035113 | |
| GeneOntologyBiologicalProcess | embryonic skeletal system development | 2.90e-05 | 148 | 50 | 5 | GO:0048706 | |
| GeneOntologyBiologicalProcess | inner ear development | 3.25e-05 | 253 | 50 | 6 | GO:0048839 | |
| GeneOntologyBiologicalProcess | endochondral bone morphogenesis | 4.01e-05 | 79 | 50 | 4 | GO:0060350 | |
| GeneOntologyBiologicalProcess | bone development | 4.12e-05 | 264 | 50 | 6 | GO:0060348 | |
| GeneOntologyBiologicalProcess | skeletal system morphogenesis | 5.38e-05 | 277 | 50 | 6 | GO:0048705 | |
| GeneOntologyBiologicalProcess | head development | COL2A1 COL3A1 MSX1 SKOR2 BHLHE22 PITX1 PBX1 PHOX2B PBX2 COL1A1 | 5.95e-05 | 919 | 50 | 10 | GO:0060322 |
| GeneOntologyBiologicalProcess | ear development | 6.30e-05 | 285 | 50 | 6 | GO:0043583 | |
| GeneOntologyBiologicalProcess | proximal/distal pattern formation | 9.83e-05 | 37 | 50 | 3 | GO:0009954 | |
| GeneOntologyBiologicalProcess | cartilage development involved in endochondral bone morphogenesis | 2.02e-04 | 47 | 50 | 3 | GO:0060351 | |
| GeneOntologyBiologicalProcess | response to acid chemical | 2.23e-04 | 228 | 50 | 5 | GO:0001101 | |
| GeneOntologyBiologicalProcess | pattern specification process | 2.60e-04 | 526 | 50 | 7 | GO:0007389 | |
| GeneOntologyBiologicalProcess | chordate embryonic development | 2.89e-04 | 906 | 50 | 9 | GO:0043009 | |
| GeneOntologyBiologicalProcess | embryonic morphogenesis | 2.91e-04 | 713 | 50 | 8 | GO:0048598 | |
| GeneOntologyBiologicalProcess | chondrocyte differentiation | 3.02e-04 | 133 | 50 | 4 | GO:0002062 | |
| GeneOntologyBiologicalProcess | embryo development ending in birth or egg hatching | 3.48e-04 | 929 | 50 | 9 | GO:0009792 | |
| GeneOntologyBiologicalProcess | ossification | 3.88e-04 | 562 | 50 | 7 | GO:0001503 | |
| GeneOntologyBiologicalProcess | positive regulation of transcription by RNA polymerase II | MSX1 FOXD3 CEBPA ESRRA BHLHE22 PITX1 RFX6 PBX1 PHOX2B PBX2 TAL1 | 4.06e-04 | 1390 | 50 | 11 | GO:0045944 |
| GeneOntologyBiologicalProcess | negative regulation of DNA-templated transcription | MSX1 FOXD3 CEBPA SAMD11 ESRRA SKOR2 BHLHE22 PITX1 ZBTB4 TAL1 DNMT3A | 4.29e-04 | 1399 | 50 | 11 | GO:0045892 |
| GeneOntologyBiologicalProcess | supramolecular fiber organization | COL2A1 COL3A1 COL18A1 COL11A1 COL28A1 COL5A3 DRG1 COL1A1 COL1A2 | 4.32e-04 | 957 | 50 | 9 | GO:0097435 |
| GeneOntologyBiologicalProcess | embryonic skeletal joint morphogenesis | 4.42e-04 | 13 | 50 | 2 | GO:0060272 | |
| GeneOntologyBiologicalProcess | negative regulation of RNA biosynthetic process | MSX1 FOXD3 CEBPA SAMD11 ESRRA SKOR2 BHLHE22 PITX1 ZBTB4 TAL1 DNMT3A | 4.67e-04 | 1413 | 50 | 11 | GO:1902679 |
| GeneOntologyBiologicalProcess | central nervous system development | COL2A1 COL3A1 MSX1 SKOR2 BHLHE22 PITX1 PBX1 PHOX2B PBX2 TAL1 | 5.10e-04 | 1197 | 50 | 10 | GO:0007417 |
| GeneOntologyBiologicalProcess | skin morphogenesis | 5.93e-04 | 15 | 50 | 2 | GO:0043589 | |
| GeneOntologyBiologicalProcess | cellular response to amino acid stimulus | 6.23e-04 | 161 | 50 | 4 | GO:0071230 | |
| GeneOntologyBiologicalProcess | muscle organ development | 6.24e-04 | 436 | 50 | 6 | GO:0007517 | |
| GeneOntologyBiologicalProcess | anatomical structure formation involved in morphogenesis | COL2A1 COL3A1 FZD8 MSX1 COL18A1 FOXD3 HOXD11 NTF4 SKOR2 TAL1 COL1A1 | 7.02e-04 | 1483 | 50 | 11 | GO:0048646 |
| GeneOntologyBiologicalProcess | embryonic skeletal joint development | 7.65e-04 | 17 | 50 | 2 | GO:0072498 | |
| GeneOntologyBiologicalProcess | negative regulation of transcription by RNA polymerase II | 8.60e-04 | 1053 | 50 | 9 | GO:0000122 | |
| GeneOntologyBiologicalProcess | cellular response to acid chemical | 8.87e-04 | 177 | 50 | 4 | GO:0071229 | |
| GeneOntologyBiologicalProcess | cellular response to growth factor stimulus | 9.30e-04 | 850 | 50 | 8 | GO:0071363 | |
| GeneOntologyBiologicalProcess | brain development | 9.95e-04 | 859 | 50 | 8 | GO:0007420 | |
| GeneOntologyBiologicalProcess | regionalization | 1.01e-03 | 478 | 50 | 6 | GO:0003002 | |
| GeneOntologyBiologicalProcess | response to growth factor | 1.19e-03 | 883 | 50 | 8 | GO:0070848 | |
| GeneOntologyBiologicalProcess | cartilage condensation | 1.41e-03 | 23 | 50 | 2 | GO:0001502 | |
| GeneOntologyBiologicalProcess | sensory organ morphogenesis | 1.42e-03 | 343 | 50 | 5 | GO:0090596 | |
| GeneOntologyBiologicalProcess | response to amino acid | 1.45e-03 | 202 | 50 | 4 | GO:0043200 | |
| GeneOntologyBiologicalProcess | notochord development | 1.54e-03 | 24 | 50 | 2 | GO:0030903 | |
| GeneOntologyBiologicalProcess | response to BMP | 1.82e-03 | 215 | 50 | 4 | GO:0071772 | |
| GeneOntologyBiologicalProcess | cellular response to BMP stimulus | 1.82e-03 | 215 | 50 | 4 | GO:0071773 | |
| GeneOntologyBiologicalProcess | central nervous system neuron differentiation | 1.88e-03 | 217 | 50 | 4 | GO:0021953 | |
| GeneOntologyBiologicalProcess | cell aggregation | 1.94e-03 | 27 | 50 | 2 | GO:0098743 | |
| GeneOntologyBiologicalProcess | muscle tissue development | 2.21e-03 | 558 | 50 | 6 | GO:0060537 | |
| GeneOntologyBiologicalProcess | visual perception | 2.32e-03 | 230 | 50 | 4 | GO:0007601 | |
| GeneOntologyBiologicalProcess | embryonic skeletal system morphogenesis | 2.35e-03 | 109 | 50 | 3 | GO:0048704 | |
| GeneOntologyBiologicalProcess | positive regulation of G2/M transition of mitotic cell cycle | 2.40e-03 | 30 | 50 | 2 | GO:0010971 | |
| GeneOntologyBiologicalProcess | sensory perception of light stimulus | 2.43e-03 | 233 | 50 | 4 | GO:0050953 | |
| GeneOntologyBiologicalProcess | embryonic hemopoiesis | 2.73e-03 | 32 | 50 | 2 | GO:0035162 | |
| GeneOntologyBiologicalProcess | cell differentiation in hindbrain | 2.73e-03 | 32 | 50 | 2 | GO:0021533 | |
| GeneOntologyBiologicalProcess | positive regulation of cell cycle G2/M phase transition | 2.90e-03 | 33 | 50 | 2 | GO:1902751 | |
| GeneOntologyBiologicalProcess | embryonic hindlimb morphogenesis | 3.26e-03 | 35 | 50 | 2 | GO:0035116 | |
| GeneOntologyCellularComponent | complex of collagen trimers | 1.18e-16 | 21 | 50 | 8 | GO:0098644 | |
| GeneOntologyCellularComponent | fibrillar collagen trimer | 2.27e-16 | 12 | 50 | 7 | GO:0005583 | |
| GeneOntologyCellularComponent | banded collagen fibril | 2.27e-16 | 12 | 50 | 7 | GO:0098643 | |
| GeneOntologyCellularComponent | collagen trimer | COL2A1 COL3A1 COL18A1 COL7A1 COL11A1 COL28A1 COL5A3 COL22A1 COL1A1 COL1A2 | 9.24e-15 | 88 | 50 | 10 | GO:0005581 |
| GeneOntologyCellularComponent | endoplasmic reticulum lumen | COL2A1 COL3A1 COL18A1 COL7A1 COL11A1 IGFBP7 NTF4 COL28A1 COL5A3 COL22A1 COL1A1 COL1A2 | 1.49e-11 | 332 | 50 | 12 | GO:0005788 |
| GeneOntologyCellularComponent | collagen-containing extracellular matrix | COL2A1 COL3A1 COL18A1 COL7A1 COL11A1 IGFBP7 COL28A1 COL5A3 COL22A1 COL1A1 COL1A2 | 3.83e-08 | 530 | 50 | 11 | GO:0062023 |
| GeneOntologyCellularComponent | extracellular matrix | COL2A1 COL3A1 COL18A1 COL7A1 COL11A1 IGFBP7 COL28A1 COL5A3 COL22A1 COL1A1 COL1A2 | 3.28e-07 | 656 | 50 | 11 | GO:0031012 |
| GeneOntologyCellularComponent | external encapsulating structure | COL2A1 COL3A1 COL18A1 COL7A1 COL11A1 IGFBP7 COL28A1 COL5A3 COL22A1 COL1A1 COL1A2 | 3.38e-07 | 658 | 50 | 11 | GO:0030312 |
| GeneOntologyCellularComponent | collagen type I trimer | 5.61e-06 | 2 | 50 | 2 | GO:0005584 | |
| GeneOntologyCellularComponent | chromatin | MSX1 FOXD3 CEBPA HOXD11 ESRRA BHLHE22 PITX1 RFX6 MRGBP PBX1 PHOX2B PBX2 TAL1 DNMT3A | 6.23e-06 | 1480 | 50 | 14 | GO:0000785 |
| GeneOntologyCellularComponent | transcription regulator complex | 1.03e-05 | 596 | 50 | 9 | GO:0005667 | |
| GeneOntologyCellularComponent | collagen type V trimer | 3.35e-05 | 4 | 50 | 2 | GO:0005588 | |
| GeneOntologyCellularComponent | collagen type XI trimer | 5.58e-05 | 5 | 50 | 2 | GO:0005592 | |
| GeneOntologyCellularComponent | basement membrane | 2.07e-04 | 122 | 50 | 4 | GO:0005604 | |
| GeneOntologyCellularComponent | supramolecular fiber | COL2A1 COL3A1 COL11A1 MAP6 COL28A1 COL5A3 KIF3C COL1A1 COL1A2 | 1.73e-03 | 1179 | 50 | 9 | GO:0099512 |
| GeneOntologyCellularComponent | supramolecular polymer | COL2A1 COL3A1 COL11A1 MAP6 COL28A1 COL5A3 KIF3C COL1A1 COL1A2 | 1.81e-03 | 1187 | 50 | 9 | GO:0099081 |
| GeneOntologyCellularComponent | nuclear periphery | 7.95e-03 | 171 | 50 | 3 | GO:0034399 | |
| HumanPheno | Arterial rupture | 3.34e-06 | 8 | 21 | 3 | HP:0025019 | |
| HumanPheno | Bell-shaped thorax | 8.09e-06 | 33 | 21 | 4 | HP:0001591 | |
| HumanPheno | Atrophic scars | 1.29e-05 | 37 | 21 | 4 | HP:0001075 | |
| HumanPheno | Fragile skin | 1.29e-05 | 37 | 21 | 4 | HP:0001030 | |
| HumanPheno | Biconcave flattened vertebrae | 1.62e-05 | 2 | 21 | 2 | HP:0003321 | |
| HumanPheno | Absent ossification of calvaria | 1.62e-05 | 2 | 21 | 2 | HP:0005623 | |
| HumanPheno | Severe generalized osteoporosis | 1.62e-05 | 2 | 21 | 2 | HP:0005897 | |
| HumanPheno | Femoral bowing present at birth, straightening with time | 1.62e-05 | 2 | 21 | 2 | HP:0005005 | |
| HumanPheno | Neonatal short-limb short stature | 2.14e-05 | 14 | 21 | 3 | HP:0008921 | |
| HumanPheno | Proportionate short stature | 2.49e-05 | 153 | 21 | 6 | HP:0003508 | |
| HumanPheno | Hypermobility of distal interphalangeal joints | 4.84e-05 | 3 | 21 | 2 | HP:0006201 | |
| HumanPheno | Popcorn calcification | 4.84e-05 | 3 | 21 | 2 | HP:6000871 | |
| HumanPheno | Thin ribs | 5.08e-05 | 52 | 21 | 4 | HP:0000883 | |
| HumanPheno | Short limb dwarfism | 5.61e-05 | 19 | 21 | 3 | HP:0003505 | |
| HumanPheno | Abnormal tibia morphology | 5.80e-05 | 107 | 21 | 5 | HP:0002992 | |
| HumanPheno | Generalized osteoporosis | 6.58e-05 | 20 | 21 | 3 | HP:0040160 | |
| HumanPheno | Dwarfism | 7.66e-05 | 21 | 21 | 3 | HP:0001516 | |
| HumanPheno | Vitreoretinopathy | 8.84e-05 | 22 | 21 | 3 | HP:0007773 | |
| HumanPheno | Cervical insufficiency | 9.67e-05 | 4 | 21 | 2 | HP:0030009 | |
| HumanPheno | Pretibial blistering | 9.67e-05 | 4 | 21 | 2 | HP:0012221 | |
| HumanPheno | Bowing of limbs due to multiple fractures | 9.67e-05 | 4 | 21 | 2 | HP:0003023 | |
| HumanPheno | Abnormality of the distal femoral epiphysis | 9.67e-05 | 4 | 21 | 2 | HP:0010590 | |
| HumanPheno | Osteoarthritis | 1.23e-04 | 65 | 21 | 4 | HP:0002758 | |
| HumanPheno | Biconcave vertebral bodies | 1.31e-04 | 25 | 21 | 3 | HP:0004586 | |
| HumanPheno | Bifid ureter | 1.61e-04 | 5 | 21 | 2 | HP:0030037 | |
| HumanPheno | Abnormality of tibial epiphyses | 1.61e-04 | 5 | 21 | 2 | HP:0006508 | |
| HumanPheno | Hypermobility of interphalangeal joints | 1.61e-04 | 5 | 21 | 2 | HP:0005620 | |
| HumanPheno | Degenerative vitreoretinopathy | 1.61e-04 | 5 | 21 | 2 | HP:0007964 | |
| HumanPheno | Basilar impression | 1.61e-04 | 5 | 21 | 2 | HP:0005758 | |
| HumanPheno | Aortic root aneurysm | 1.64e-04 | 70 | 21 | 4 | HP:0002616 | |
| HumanPheno | Dermal translucency | 1.66e-04 | 27 | 21 | 3 | HP:0010648 | |
| HumanPheno | Congenital onset | COL2A1 COL3A1 COL18A1 COL7A1 COL11A1 KMT2B PITX1 RFX6 PHOX2B DNMT3A DRG1 COL1A1 COL1A2 | 2.01e-04 | 1206 | 21 | 13 | HP:0003577 |
| HumanPheno | Atypical scarring of skin | 2.04e-04 | 74 | 21 | 4 | HP:0000987 | |
| HumanPheno | Avascular necrosis of the capital femoral epiphysis | 2.28e-04 | 30 | 21 | 3 | HP:0005743 | |
| HumanPheno | Crumpled long bones | 2.40e-04 | 6 | 21 | 2 | HP:0006367 | |
| HumanPheno | Joint subluxation | 2.52e-04 | 31 | 21 | 3 | HP:0032153 | |
| HumanPheno | Stillbirth | 2.77e-04 | 32 | 21 | 3 | HP:0003826 | |
| HumanPheno | Dilatation of the ascending aorta | 3.33e-04 | 84 | 21 | 4 | HP:0005111 | |
| HumanPheno | Otosclerosis | 3.36e-04 | 7 | 21 | 2 | HP:0000362 | |
| HumanPheno | Lens luxation | 3.36e-04 | 7 | 21 | 2 | HP:0012019 | |
| HumanPheno | Molluscoid pseudotumors | 3.36e-04 | 7 | 21 | 2 | HP:0000993 | |
| HumanPheno | Dumbbell-shaped long bone | 3.36e-04 | 7 | 21 | 2 | HP:0000947 | |
| HumanPheno | Angle closure glaucoma | 3.36e-04 | 7 | 21 | 2 | HP:0012109 | |
| HumanPheno | Uterine prolapse | 3.36e-04 | 7 | 21 | 2 | HP:0000139 | |
| HumanPheno | Broad long bones | 3.56e-04 | 157 | 21 | 5 | HP:0005622 | |
| HumanPheno | Abnormal femoral epiphysis morphology | 3.64e-04 | 86 | 21 | 4 | HP:0006499 | |
| HumanPheno | Bladder diverticulum | 3.95e-04 | 36 | 21 | 3 | HP:0000015 | |
| HumanPheno | Abnormality of the bladder | 4.23e-04 | 621 | 21 | 9 | HP:0000014 | |
| HumanPheno | Thin skin | 4.33e-04 | 90 | 21 | 4 | HP:0000963 | |
| HumanPheno | Genital hernia | 4.47e-04 | 8 | 21 | 2 | HP:0100823 | |
| HumanPheno | Coxa valga | 4.71e-04 | 92 | 21 | 4 | HP:0002673 | |
| HumanPheno | Decreased skull ossification | 5.02e-04 | 39 | 21 | 3 | HP:0004331 | |
| HumanPheno | Abnormal lower limb epiphysis morphology | 5.12e-04 | 94 | 21 | 4 | HP:0006500 | |
| HumanPheno | Enlarged thorax | 5.12e-04 | 94 | 21 | 4 | HP:0100625 | |
| HumanPheno | Subcutaneous nodule | 5.33e-04 | 95 | 21 | 4 | HP:0001482 | |
| HumanPheno | Tibial bowing | 5.82e-04 | 41 | 21 | 3 | HP:0002982 | |
| HumanPheno | Premature birth | 6.19e-04 | 177 | 21 | 5 | HP:0001622 | |
| HumanPheno | Lens dislocation | 6.70e-04 | 43 | 21 | 3 | HP:0000665 | |
| HumanPheno | Juvenile aseptic necrosis | 6.70e-04 | 43 | 21 | 3 | HP:0100323 | |
| HumanPheno | Ectopia lentis | 6.70e-04 | 43 | 21 | 3 | HP:0001083 | |
| HumanPheno | Scarring | 6.98e-04 | 102 | 21 | 4 | HP:0100699 | |
| HumanPheno | Cigarette-paper scars | 7.14e-04 | 10 | 21 | 2 | HP:0001073 | |
| HumanPheno | Irregular femoral epiphysis | 7.14e-04 | 10 | 21 | 2 | HP:0006361 | |
| HumanPheno | Talipes equinovarus | 7.59e-04 | 399 | 21 | 7 | HP:0001762 | |
| HumanPheno | Dermal atrophy | 8.36e-04 | 107 | 21 | 4 | HP:0004334 | |
| HumanPheno | Multiple rib fractures | 8.71e-04 | 11 | 21 | 2 | HP:0006640 | |
| HumanPheno | Flared metaphysis | 8.76e-04 | 191 | 21 | 5 | HP:0003015 | |
| HumanPheno | Abnormal patella morphology | 8.97e-04 | 109 | 21 | 4 | HP:0003045 | |
| HumanPheno | Disproportionate short-limb short stature | 8.97e-04 | 109 | 21 | 4 | HP:0008873 | |
| HumanPheno | Severe short stature | 9.60e-04 | 111 | 21 | 4 | HP:0003510 | |
| HumanPheno | Abnormal vitreous humor morphology | 9.85e-04 | 49 | 21 | 3 | HP:0004327 | |
| HumanPheno | Arterial dissection | 1.04e-03 | 12 | 21 | 2 | HP:0005294 | |
| HumanPheno | Arteriovenous fistula | 1.04e-03 | 12 | 21 | 2 | HP:0004947 | |
| HumanPheno | Encephalomalacia | 1.04e-03 | 12 | 21 | 2 | HP:0040197 | |
| HumanPheno | Femoral bowing | 1.05e-03 | 50 | 21 | 3 | HP:0002980 | |
| HumanPheno | Finger joint hypermobility | 1.17e-03 | 52 | 21 | 3 | HP:0006094 | |
| HumanPheno | Retinal detachment | 1.21e-03 | 118 | 21 | 4 | HP:0000541 | |
| HumanPheno | Protrusio acetabuli | 1.23e-03 | 13 | 21 | 2 | HP:0003179 | |
| HumanPheno | Spondyloepiphyseal dysplasia | 1.23e-03 | 13 | 21 | 2 | HP:0002655 | |
| HumanPheno | Abnormal uterine cervix morphology | 1.23e-03 | 13 | 21 | 2 | HP:0012888 | |
| HumanPheno | Aplasia/Hypoplasia of the earlobes | 1.24e-03 | 53 | 21 | 3 | HP:0009906 | |
| HumanPheno | Papule | 1.32e-03 | 209 | 21 | 5 | HP:0200034 | |
| HumanPheno | Thoracic aortic aneurysm | 1.33e-03 | 121 | 21 | 4 | HP:0012727 | |
| HumanPheno | Abnormal hallux morphology | 1.40e-03 | 212 | 21 | 5 | HP:0001844 | |
| HumanPheno | Mitral valve prolapse | 1.41e-03 | 123 | 21 | 4 | HP:0001634 | |
| HumanPheno | Recurrent joint dislocation | 1.43e-03 | 14 | 21 | 2 | HP:0031869 | |
| HumanPheno | Soft, doughy skin | 1.43e-03 | 14 | 21 | 2 | HP:0001027 | |
| HumanPheno | Platyspondyly | 1.45e-03 | 124 | 21 | 4 | HP:0000926 | |
| HumanPheno | Talipes | 1.47e-03 | 583 | 21 | 8 | HP:0001883 | |
| HumanPheno | Vascular dilatation | 1.49e-03 | 215 | 21 | 5 | HP:0002617 | |
| HumanPheno | Abdominal aortic aneurysm | 1.50e-03 | 125 | 21 | 4 | HP:0005112 | |
| HumanPheno | Abnormality of the calcaneus | 1.53e-03 | 57 | 21 | 3 | HP:0008364 | |
| HumanPheno | Limb pain | 1.53e-03 | 57 | 21 | 3 | HP:0009763 | |
| HumanPheno | Abnormality of hand joint mobility | 1.53e-03 | 57 | 21 | 3 | HP:0006256 | |
| HumanPheno | Positional foot deformity | 1.53e-03 | 587 | 21 | 8 | HP:0005656 | |
| HumanPheno | Hydrops fetalis | 1.54e-03 | 126 | 21 | 4 | HP:0001789 | |
| HumanPheno | Hernia | 1.57e-03 | 589 | 21 | 8 | HP:0100790 | |
| HumanPheno | Lens subluxation | 1.65e-03 | 15 | 21 | 2 | HP:0001132 | |
| HumanPheno | Knee osteoarthritis | 1.65e-03 | 15 | 21 | 2 | HP:0005086 | |
| HumanPheno | Muscle flaccidity | 1.65e-03 | 15 | 21 | 2 | HP:0010547 | |
| MousePheno | perinatal lethality, complete penetrance | COL2A1 MSX1 COL11A1 CEBPA KMT2B SKOR2 PITX1 PHOX2B KCNT1 COL1A1 COL1A2 | 5.56e-06 | 712 | 42 | 11 | MP:0011089 |
| MousePheno | abnormal pelvic girdle bone morphology | 5.90e-06 | 87 | 42 | 5 | MP:0004509 | |
| MousePheno | lethality during fetal growth through weaning, complete penetrance | COL2A1 MSX1 COL7A1 COL11A1 CEBPA KMT2B SKOR2 PITX1 PBX1 PHOX2B KCNT1 DNMT3A COL1A1 COL1A2 | 1.11e-05 | 1269 | 42 | 14 | MP:0011111 |
| MousePheno | absent common myeloid progenitor cells | 1.12e-05 | 15 | 42 | 3 | MP:0000239 | |
| MousePheno | abnormal joint mobility | 1.67e-05 | 17 | 42 | 3 | MP:0008069 | |
| MousePheno | cleft palate | 2.18e-05 | 289 | 42 | 7 | MP:0000111 | |
| MousePheno | oral cleft | 2.28e-05 | 291 | 42 | 7 | MP:0021164 | |
| MousePheno | cleft secondary palate | 3.72e-05 | 127 | 42 | 5 | MP:0009890 | |
| MousePheno | short mandible | 3.92e-05 | 64 | 42 | 4 | MP:0000088 | |
| MousePheno | abnormal palate morphology | 4.26e-05 | 321 | 42 | 7 | MP:0003755 | |
| MousePheno | abnormal knee morphology | 4.28e-05 | 23 | 42 | 3 | MP:0030881 | |
| MousePheno | abnormal sleep behavior | 5.34e-05 | 137 | 42 | 5 | MP:0011396 | |
| MousePheno | abnormal fourth ventricle morphology | 5.54e-05 | 25 | 42 | 3 | MP:0000828 | |
| MousePheno | abnormal limb joint morphology | 5.54e-05 | 25 | 42 | 3 | MP:0030805 | |
| MousePheno | perinatal lethality | COL2A1 MSX1 COL11A1 CEBPA KMT2B MAP6 SKOR2 PITX1 PHOX2B KCNT1 COL1A1 COL1A2 | 8.29e-05 | 1130 | 42 | 12 | MP:0002081 |
| MousePheno | shortened head | 8.73e-05 | 29 | 42 | 3 | MP:0000435 | |
| MousePheno | abnormal compact bone lamellar structure | 8.76e-05 | 5 | 42 | 2 | MP:0010970 | |
| MousePheno | decreased tendon stiffness | 8.76e-05 | 5 | 42 | 2 | MP:0003098 | |
| MousePheno | abnormal secondary palate morphology | 1.08e-04 | 159 | 42 | 5 | MP:0013550 | |
| MousePheno | micromelia | 1.31e-04 | 6 | 42 | 2 | MP:0008736 | |
| MousePheno | abnormal tendon stiffness | 1.31e-04 | 6 | 42 | 2 | MP:0003097 | |
| MousePheno | abnormal tendon physiology | 1.31e-04 | 6 | 42 | 2 | MP:0030802 | |
| MousePheno | abnormal mouth morphology | 1.36e-04 | 670 | 42 | 9 | MP:0000452 | |
| MousePheno | small pancreas | 1.41e-04 | 34 | 42 | 3 | MP:0004247 | |
| MousePheno | abnormal malleus morphology | 1.41e-04 | 34 | 42 | 3 | MP:0000029 | |
| MousePheno | abnormal bone volume | 1.61e-04 | 173 | 42 | 5 | MP:0010874 | |
| MousePheno | neonatal lethality, complete penetrance | 1.61e-04 | 534 | 42 | 8 | MP:0011087 | |
| MousePheno | decreased bone volume | 2.24e-04 | 100 | 42 | 4 | MP:0010876 | |
| MousePheno | dilated fourth ventricle | 2.44e-04 | 8 | 42 | 2 | MP:0000829 | |
| MousePheno | short facial bone | 2.60e-04 | 104 | 42 | 4 | MP:0030384 | |
| MousePheno | abnormal dermal layer morphology | 3.01e-04 | 108 | 42 | 4 | MP:0001243 | |
| MousePheno | aortic dissection | 3.13e-04 | 9 | 42 | 2 | MP:0004044 | |
| MousePheno | abnormal knee joint morphology | 3.13e-04 | 9 | 42 | 2 | MP:0030837 | |
| MousePheno | palatal shelf hypoplasia | 3.13e-04 | 9 | 42 | 2 | MP:0009883 | |
| MousePheno | abnormal skeleton development | 3.34e-04 | 447 | 42 | 7 | MP:0002113 | |
| MousePheno | short limbs | 3.34e-04 | 111 | 42 | 4 | MP:0000547 | |
| MousePheno | abnormal rhythmic behavior | 3.46e-04 | 204 | 42 | 5 | MP:0021121 | |
| MousePheno | decreased common myeloid progenitor cell number | 3.73e-04 | 47 | 42 | 3 | MP:0008813 | |
| MousePheno | abnormal ischium morphology | 3.91e-04 | 10 | 42 | 2 | MP:0004507 | |
| MousePheno | small mandible | 3.95e-04 | 116 | 42 | 4 | MP:0004592 | |
| MousePheno | abnormal palatal shelf morphology | 4.64e-04 | 121 | 42 | 4 | MP:0031460 | |
| MousePheno | abnormal skin appearance | 4.69e-04 | 473 | 42 | 7 | MP:0009931 | |
| MousePheno | abnormal fibula morphology | 4.75e-04 | 51 | 42 | 3 | MP:0002187 | |
| MousePheno | abnormal ilium morphology | 4.76e-04 | 11 | 42 | 2 | MP:0005354 | |
| MousePheno | neonatal lethality | 5.04e-04 | 799 | 42 | 9 | MP:0002058 | |
| MousePheno | abnormal secondary palate development | 5.09e-04 | 124 | 42 | 4 | MP:0009655 | |
| MousePheno | abnormal synovial joint morphology | 5.09e-04 | 124 | 42 | 4 | MP:0030804 | |
| MousePheno | abnormal adipose tissue physiology | 5.57e-04 | 127 | 42 | 4 | MP:0005666 | |
| MousePheno | abnormal palate development | 5.91e-04 | 129 | 42 | 4 | MP:0009653 | |
| MousePheno | abnormal middle ear ossicle morphology | 6.26e-04 | 56 | 42 | 3 | MP:0005105 | |
| MousePheno | abnormal pancreas size | 6.59e-04 | 57 | 42 | 3 | MP:0009106 | |
| MousePheno | abnormal proximal-distal axis patterning | 6.73e-04 | 13 | 42 | 2 | MP:0001705 | |
| MousePheno | abnormal nodose ganglion morphology | 6.73e-04 | 13 | 42 | 2 | MP:0001087 | |
| MousePheno | fused carpal bones | 7.84e-04 | 14 | 42 | 2 | MP:0008915 | |
| MousePheno | abnormal petrosal ganglion morphology | 7.84e-04 | 14 | 42 | 2 | MP:0001084 | |
| MousePheno | abnormal long bone morphology | 7.85e-04 | 676 | 42 | 8 | MP:0003723 | |
| MousePheno | abnormal digestive system morphology | COL2A1 COL3A1 MSX1 COL7A1 COL11A1 SKOR2 PITX1 PBX1 CRAMP1 DRG1 COL1A1 | 7.94e-04 | 1233 | 42 | 11 | MP:0000462 |
| MousePheno | abnormal skin morphology | COL3A1 COL7A1 DLGAP3 CEBPA IGFBP7 NTF4 BHLHE22 PBX1 TAL1 DRG1 COL1A1 COL1A2 | 8.74e-04 | 1455 | 42 | 12 | MP:0002060 |
| MousePheno | small snout | 8.92e-04 | 144 | 42 | 4 | MP:0030190 | |
| MousePheno | abnormal osteocyte morphology | 9.03e-04 | 15 | 42 | 2 | MP:0008753 | |
| MousePheno | decreased chondrocyte proliferation | 1.03e-03 | 16 | 42 | 2 | MP:0014101 | |
| MousePheno | abnormal joint morphology | 1.12e-03 | 397 | 42 | 6 | MP:0002932 | |
| MousePheno | abnormal bone marrow cell number | 1.14e-03 | 154 | 42 | 4 | MP:0000172 | |
| MousePheno | digestive/alimentary phenotype | COL2A1 COL3A1 MSX1 COL7A1 COL11A1 SKOR2 PITX1 RFX6 PBX1 CRAMP1 DRG1 COL1A1 | 1.15e-03 | 1500 | 42 | 12 | MP:0005381 |
| MousePheno | decreased bone trabecula number | 1.20e-03 | 70 | 42 | 3 | MP:0010869 | |
| MousePheno | abnormal facial morphology | 1.28e-03 | 910 | 42 | 9 | MP:0003743 | |
| MousePheno | absent middle ear ossicles | 1.31e-03 | 18 | 42 | 2 | MP:0000040 | |
| MousePheno | abnormal geniculate ganglion morphology | 1.31e-03 | 18 | 42 | 2 | MP:0001082 | |
| MousePheno | abnormal osteocyte lacunocanalicular system morphology | 1.31e-03 | 18 | 42 | 2 | MP:0030485 | |
| MousePheno | abnormal head morphology | COL2A1 MSX1 COL7A1 COL11A1 KMT2B SKOR2 PITX1 PBX1 CRAMP1 COL1A1 | 1.44e-03 | 1120 | 42 | 10 | MP:0000432 |
| MousePheno | small vertebral body | 1.46e-03 | 19 | 42 | 2 | MP:0004670 | |
| MousePheno | respiratory failure | 1.48e-03 | 165 | 42 | 4 | MP:0001953 | |
| MousePheno | abnormal phalanx morphology | 1.52e-03 | 76 | 42 | 3 | MP:0005306 | |
| MousePheno | abnormal craniofacial development | 1.58e-03 | 425 | 42 | 6 | MP:0003935 | |
| MousePheno | abnormal chondrocyte proliferation | 1.62e-03 | 20 | 42 | 2 | MP:0014099 | |
| MousePheno | enhanced fertility | 1.62e-03 | 20 | 42 | 2 | MP:0010143 | |
| MousePheno | abnormal hindlimb joint morphology | 1.62e-03 | 20 | 42 | 2 | MP:0030808 | |
| MousePheno | increased litter size | 1.62e-03 | 20 | 42 | 2 | MP:0001934 | |
| MousePheno | decreased adipocyte glucose uptake | 1.62e-03 | 20 | 42 | 2 | MP:0030017 | |
| MousePheno | decreased respiration | 1.65e-03 | 170 | 42 | 4 | MP:0014274 | |
| MousePheno | abnormal trabecular bone morphology | 1.66e-03 | 289 | 42 | 5 | MP:0000130 | |
| MousePheno | osteoarthritis | 1.78e-03 | 21 | 42 | 2 | MP:0003560 | |
| MousePheno | increased heart ventricle size | 1.83e-03 | 175 | 42 | 4 | MP:0008772 | |
| MousePheno | abnormal respiration | 1.85e-03 | 598 | 42 | 7 | MP:0001943 | |
| MousePheno | abnormal mandible morphology | 1.87e-03 | 176 | 42 | 4 | MP:0000458 | |
| MousePheno | thick dermal layer | 1.96e-03 | 22 | 42 | 2 | MP:0001245 | |
| MousePheno | abnormal pubis morphology | 1.96e-03 | 22 | 42 | 2 | MP:0004506 | |
| MousePheno | abnormal aorta elastic tissue morphology | 1.96e-03 | 22 | 42 | 2 | MP:0009862 | |
| MousePheno | abnormal chondrocyte morphology | 1.96e-03 | 83 | 42 | 3 | MP:0000166 | |
| MousePheno | abnormal bone structure | COL2A1 COL7A1 COL11A1 USP51 ESRRA PITX1 HSD17B1 CRAMP1 DNMT3A COL1A1 COL1A2 | 1.99e-03 | 1379 | 42 | 11 | MP:0003795 |
| MousePheno | abnormal ulna morphology | 2.03e-03 | 84 | 42 | 3 | MP:0005108 | |
| MousePheno | decreased percent body fat/body weight | 2.03e-03 | 84 | 42 | 3 | MP:0005459 | |
| MousePheno | adipose tissue phenotype | COL2A1 COL3A1 CEBPA KMT2B ESRRA PITX1 COL5A3 HSD17B1 DNMT3A COL1A1 COL1A2 | 2.04e-03 | 1383 | 42 | 11 | MP:0005375 |
| MousePheno | abnormal breathing pattern | 2.04e-03 | 303 | 42 | 5 | MP:0001951 | |
| MousePheno | abnormal forelimb morphology | 2.11e-03 | 182 | 42 | 4 | MP:0000550 | |
| MousePheno | decreased palatal shelf size | 2.14e-03 | 23 | 42 | 2 | MP:0031462 | |
| MousePheno | abnormal neuron number | 2.26e-03 | 456 | 42 | 6 | MP:0008946 | |
| MousePheno | abnormal palatal shelf size | 2.33e-03 | 24 | 42 | 2 | MP:0031461 | |
| MousePheno | abnormal blood vessel elastic tissue morphology | 2.33e-03 | 24 | 42 | 2 | MP:0006083 | |
| MousePheno | abnormal ciliary body morphology | 2.33e-03 | 24 | 42 | 2 | MP:0005099 | |
| Domain | Collagen | COL2A1 COL3A1 COL18A1 COL7A1 COL11A1 COL28A1 COL5A3 COL22A1 COL1A1 COL1A2 | 1.25e-14 | 85 | 48 | 10 | PF01391 |
| Domain | Collagen | COL2A1 COL3A1 COL18A1 COL7A1 COL11A1 COL28A1 COL5A3 COL22A1 COL1A1 COL1A2 | 1.25e-14 | 85 | 48 | 10 | IPR008160 |
| Domain | NC1_FIB | 9.53e-14 | 11 | 48 | 6 | PS51461 | |
| Domain | Fib_collagen_C | 9.53e-14 | 11 | 48 | 6 | IPR000885 | |
| Domain | Fib_collagen_C | 9.53e-14 | 11 | 48 | 6 | PD002078 | |
| Domain | COLFI | 9.53e-14 | 11 | 48 | 6 | SM00038 | |
| Domain | COLFI | 9.53e-14 | 11 | 48 | 6 | PF01410 | |
| Domain | TSPN | 3.28e-07 | 23 | 48 | 4 | SM00210 | |
| Domain | Homeobox_CS | 7.80e-06 | 186 | 48 | 6 | IPR017970 | |
| Domain | Laminin_G | 1.47e-05 | 58 | 48 | 4 | IPR001791 | |
| Domain | Homeobox | 2.87e-05 | 234 | 48 | 6 | PF00046 | |
| Domain | HOMEOBOX_1 | 3.01e-05 | 236 | 48 | 6 | PS00027 | |
| Domain | HOX | 3.08e-05 | 237 | 48 | 6 | SM00389 | |
| Domain | Homeobox_dom | 3.23e-05 | 239 | 48 | 6 | IPR001356 | |
| Domain | HOMEOBOX_2 | 3.23e-05 | 239 | 48 | 6 | PS50071 | |
| Domain | PBC | 3.87e-05 | 4 | 48 | 2 | PF03792 | |
| Domain | PBX | 3.87e-05 | 4 | 48 | 2 | IPR005542 | |
| Domain | VWC | 4.99e-05 | 28 | 48 | 3 | PF00093 | |
| Domain | - | 8.25e-05 | 283 | 48 | 6 | 1.10.10.60 | |
| Domain | VWFC_1 | 1.07e-04 | 36 | 48 | 3 | PS01208 | |
| Domain | VWC | 1.26e-04 | 38 | 48 | 3 | SM00214 | |
| Domain | VWFC_2 | 1.26e-04 | 38 | 48 | 3 | PS50184 | |
| Domain | VWF_dom | 1.70e-04 | 42 | 48 | 3 | IPR001007 | |
| Domain | LamG | 1.96e-04 | 44 | 48 | 3 | SM00282 | |
| Domain | Homeodomain-like | 1.97e-04 | 332 | 48 | 6 | IPR009057 | |
| Domain | ConA-like_dom | 2.41e-04 | 219 | 48 | 5 | IPR013320 | |
| Domain | VWA | 4.01e-04 | 56 | 48 | 3 | PF00092 | |
| Domain | - | 9.09e-04 | 74 | 48 | 3 | 3.40.50.410 | |
| Domain | - | 9.64e-04 | 18 | 48 | 2 | 4.10.410.10 | |
| Domain | Prtase_inh_Kunz-CS | 9.64e-04 | 18 | 48 | 2 | IPR020901 | |
| Domain | BPTI_KUNITZ_2 | 1.08e-03 | 19 | 48 | 2 | PS50279 | |
| Domain | Kunitz_BPTI | 1.08e-03 | 19 | 48 | 2 | PF00014 | |
| Domain | BPTI_KUNITZ_1 | 1.08e-03 | 19 | 48 | 2 | PS00280 | |
| Domain | FRI | 1.19e-03 | 20 | 48 | 2 | SM00063 | |
| Domain | VWFA | 1.22e-03 | 82 | 48 | 3 | PS50234 | |
| Domain | VWA | 1.31e-03 | 84 | 48 | 3 | SM00327 | |
| Domain | - | 1.32e-03 | 21 | 48 | 2 | 1.10.2000.10 | |
| Domain | Kunitz_BPTI | 1.58e-03 | 23 | 48 | 2 | IPR002223 | |
| Domain | Frizzled_dom | 1.72e-03 | 24 | 48 | 2 | IPR020067 | |
| Domain | FZ | 1.72e-03 | 24 | 48 | 2 | PS50038 | |
| Domain | Fz | 1.72e-03 | 24 | 48 | 2 | PF01392 | |
| Domain | VWF_A | 2.10e-03 | 99 | 48 | 3 | IPR002035 | |
| Domain | Laminin_G_2 | 4.74e-03 | 40 | 48 | 2 | PF02210 | |
| Domain | Znf_FYVE_PHD | 6.38e-03 | 147 | 48 | 3 | IPR011011 | |
| Pathway | REACTOME_COLLAGEN_CHAIN_TRIMERIZATION | COL2A1 COL3A1 COL18A1 COL7A1 COL11A1 COL28A1 COL5A3 COL22A1 COL1A1 COL1A2 | 1.65e-18 | 41 | 34 | 10 | MM15538 |
| Pathway | REACTOME_COLLAGEN_CHAIN_TRIMERIZATION | COL2A1 COL3A1 COL18A1 COL7A1 COL11A1 COL28A1 COL5A3 COL22A1 COL1A1 COL1A2 | 3.63e-18 | 44 | 34 | 10 | M27812 |
| Pathway | REACTOME_COLLAGEN_BIOSYNTHESIS_AND_MODIFYING_ENZYMES | COL2A1 COL3A1 COL18A1 COL7A1 COL11A1 COL28A1 COL5A3 COL22A1 COL1A1 COL1A2 | 1.28e-16 | 61 | 34 | 10 | MM14637 |
| Pathway | REACTOME_COLLAGEN_BIOSYNTHESIS_AND_MODIFYING_ENZYMES | COL2A1 COL3A1 COL18A1 COL7A1 COL11A1 COL28A1 COL5A3 COL22A1 COL1A1 COL1A2 | 3.50e-16 | 67 | 34 | 10 | M26999 |
| Pathway | REACTOME_COLLAGEN_FORMATION | COL2A1 COL3A1 COL18A1 COL7A1 COL11A1 COL28A1 COL5A3 COL22A1 COL1A1 COL1A2 | 1.33e-15 | 76 | 34 | 10 | MM14573 |
| Pathway | REACTOME_COLLAGEN_FORMATION | COL2A1 COL3A1 COL18A1 COL7A1 COL11A1 COL28A1 COL5A3 COL22A1 COL1A1 COL1A2 | 7.78e-15 | 90 | 34 | 10 | M631 |
| Pathway | REACTOME_ASSEMBLY_OF_COLLAGEN_FIBRILS_AND_OTHER_MULTIMERIC_STRUCTURES | 2.36e-13 | 50 | 34 | 8 | MM14796 | |
| Pathway | REACTOME_COLLAGEN_DEGRADATION | 3.87e-13 | 53 | 34 | 8 | MM14566 | |
| Pathway | REACTOME_ASSEMBLY_OF_COLLAGEN_FIBRILS_AND_OTHER_MULTIMERIC_STRUCTURES | 1.27e-12 | 61 | 34 | 8 | M27103 | |
| Pathway | REACTOME_COLLAGEN_DEGRADATION | 1.90e-12 | 64 | 34 | 8 | M26953 | |
| Pathway | REACTOME_MET_ACTIVATES_PTK2_SIGNALING | 3.28e-12 | 19 | 34 | 6 | MM15512 | |
| Pathway | REACTOME_MET_ACTIVATES_PTK2_SIGNALING | 7.04e-11 | 30 | 34 | 6 | M27772 | |
| Pathway | REACTOME_MET_PROMOTES_CELL_MOTILITY | 7.04e-11 | 30 | 34 | 6 | MM15517 | |
| Pathway | REACTOME_NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS | 1.07e-10 | 32 | 34 | 6 | MM14924 | |
| Pathway | PID_INTEGRIN1_PATHWAY | 1.73e-10 | 66 | 34 | 7 | M18 | |
| Pathway | REACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX | 2.17e-10 | 114 | 34 | 8 | MM14571 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | COL2A1 COL3A1 COL18A1 COL7A1 COL11A1 COL28A1 COL5A3 COL22A1 COL1A1 COL1A2 | 3.16e-10 | 258 | 34 | 10 | MM14572 |
| Pathway | REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS | 4.78e-10 | 76 | 34 | 7 | MM14867 | |
| Pathway | REACTOME_MET_PROMOTES_CELL_MOTILITY | 5.23e-10 | 41 | 34 | 6 | M27778 | |
| Pathway | REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS | 1.06e-09 | 85 | 34 | 7 | M16441 | |
| Pathway | PID_SYNDECAN_1_PATHWAY | 1.08e-09 | 46 | 34 | 6 | M198 | |
| Pathway | REACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX | 1.13e-09 | 140 | 34 | 8 | M587 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | COL2A1 COL3A1 COL18A1 COL7A1 COL11A1 COL28A1 COL5A3 COL22A1 COL1A1 COL1A2 | 1.37e-09 | 300 | 34 | 10 | M610 |
| Pathway | REACTOME_NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS | 5.08e-09 | 59 | 34 | 6 | M27218 | |
| Pathway | REACTOME_SIGNALING_BY_MET | 1.11e-08 | 67 | 34 | 6 | MM15345 | |
| Pathway | PID_AVB3_INTEGRIN_PATHWAY | 2.04e-08 | 74 | 34 | 6 | M160 | |
| Pathway | REACTOME_SIGNALING_BY_MET | 3.03e-08 | 79 | 34 | 6 | M27643 | |
| Pathway | KEGG_ECM_RECEPTOR_INTERACTION | 4.40e-08 | 84 | 34 | 6 | M7098 | |
| Pathway | REACTOME_ECM_PROTEOGLYCANS | 8.57e-08 | 47 | 34 | 5 | MM14925 | |
| Pathway | REACTOME_SYNDECAN_INTERACTIONS | 4.76e-07 | 27 | 34 | 4 | M27217 | |
| Pathway | WP_DYSREGULATED_MIRNA_TARGETING_IN_INSULINPI3KAKT_SIGNALING | 5.54e-07 | 28 | 34 | 4 | MM15957 | |
| Pathway | REACTOME_ECM_PROTEOGLYCANS | 9.82e-07 | 76 | 34 | 5 | M27219 | |
| Pathway | WP_FOCAL_ADHESION | 4.97e-06 | 187 | 34 | 6 | MM15913 | |
| Pathway | REACTOME_ANCHORING_FIBRIL_FORMATION | 5.72e-06 | 15 | 34 | 3 | M27161 | |
| Pathway | KEGG_FOCAL_ADHESION | 7.10e-06 | 199 | 34 | 6 | M7253 | |
| Pathway | REACTOME_SCAVENGING_BY_CLASS_A_RECEPTORS | 1.21e-05 | 19 | 34 | 3 | M27221 | |
| Pathway | REACTOME_NCAM1_INTERACTIONS | 1.42e-05 | 20 | 34 | 3 | MM15061 | |
| Pathway | WP_INFLAMMATORY_RESPONSE_PATHWAY | 4.98e-05 | 30 | 34 | 3 | M39641 | |
| Pathway | WP_INFLAMMATORY_RESPONSE_PATHWAY | 4.98e-05 | 30 | 34 | 3 | MM15812 | |
| Pathway | REACTOME_SIGNALING_BY_RECEPTOR_TYROSINE_KINASES | 5.15e-05 | 418 | 34 | 7 | MM15587 | |
| Pathway | WP_FOCAL_ADHESION_PI3KAKTMTORSIGNALING | 7.46e-05 | 302 | 34 | 6 | M39719 | |
| Pathway | WP_NEURAL_CREST_DIFFERENTIATION | 9.76e-05 | 101 | 34 | 4 | M39448 | |
| Pathway | REACTOME_NCAM_SIGNALING_FOR_NEURITE_OUT_GROWTH | 1.02e-04 | 38 | 34 | 3 | MM14969 | |
| Pathway | WP_FOCAL_ADHESION_PI3KAKTMTOR_SIGNALING_PATHWAY | 1.14e-04 | 326 | 34 | 6 | MM15917 | |
| Pathway | REACTOME_ENHANCED_BINDING_OF_GP1BA_VARIANT_TO_VWF_MULTIMER_COLLAGEN | 1.18e-04 | 7 | 34 | 2 | M48265 | |
| Pathway | REACTOME_NCAM1_INTERACTIONS | 1.38e-04 | 42 | 34 | 3 | M7169 | |
| Pathway | WP_MIRNA_TARGETS_IN_ECM_AND_MEMBRANE_RECEPTORS | 1.48e-04 | 43 | 34 | 3 | M39565 | |
| Pathway | REACTOME_DEFECTS_OF_PLATELET_ADHESION_TO_EXPOSED_COLLAGEN | 1.57e-04 | 8 | 34 | 2 | M48236 | |
| Pathway | REACTOME_SIGNALING_BY_RECEPTOR_TYROSINE_KINASES | 2.32e-04 | 532 | 34 | 7 | M27870 | |
| Pathway | WP_OSTEOARTHRITIC_CHONDROCYTE_HYPERTROPHY | 2.33e-04 | 50 | 34 | 3 | M48087 | |
| Pathway | REACTOME_IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL | 2.99e-04 | 135 | 34 | 4 | MM14781 | |
| Pathway | REACTOME_SIGNALING_BY_PDGF | 3.43e-04 | 57 | 34 | 3 | MM14713 | |
| Pathway | REACTOME_SIGNALING_BY_PDGF | 3.61e-04 | 58 | 34 | 3 | M2049 | |
| Pathway | REACTOME_GP1B_IX_V_ACTIVATION_SIGNALLING | 3.67e-04 | 12 | 34 | 2 | MM15093 | |
| Pathway | REACTOME_GP1B_IX_V_ACTIVATION_SIGNALLING | 3.67e-04 | 12 | 34 | 2 | M27352 | |
| Pathway | REACTOME_PLATELET_ADHESION_TO_EXPOSED_COLLAGEN | 3.67e-04 | 12 | 34 | 2 | MM15452 | |
| Pathway | PID_MYC_REPRESS_PATHWAY | 4.61e-04 | 63 | 34 | 3 | M254 | |
| Pathway | REACTOME_NCAM_SIGNALING_FOR_NEURITE_OUT_GROWTH | 4.61e-04 | 63 | 34 | 3 | M11187 | |
| Pathway | WP_UROTENSINIIMEDIATED_SIGNALING | 6.02e-04 | 69 | 34 | 3 | M48052 | |
| Pathway | REACTOME_PLATELET_ADHESION_TO_EXPOSED_COLLAGEN | 6.63e-04 | 16 | 34 | 2 | M9450 | |
| Pathway | WP_INTERACTIONS_BETWEEN_LOXL4_AND_OXIDATIVE_STRESS_PATHWAY | 8.43e-04 | 18 | 34 | 2 | M39586 | |
| Pathway | WP_MIR5093P_ALTERATION_OF_YAP1ECM_AXIS | 8.43e-04 | 18 | 34 | 2 | M39421 | |
| Pathway | REACTOME_CROSSLINKING_OF_COLLAGEN_FIBRILS | 8.43e-04 | 18 | 34 | 2 | M27164 | |
| Pathway | REACTOME_CROSSLINKING_OF_COLLAGEN_FIBRILS | 8.43e-04 | 18 | 34 | 2 | MM14882 | |
| Pathway | REACTOME_DISEASES_OF_HEMOSTASIS | 9.41e-04 | 19 | 34 | 2 | M48230 | |
| Pathway | REACTOME_IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL | 1.08e-03 | 190 | 34 | 4 | M8240 | |
| Pathway | WP_FOCAL_ADHESION | 1.28e-03 | 199 | 34 | 4 | M39402 | |
| Pathway | REACTOME_DEVELOPMENTAL_BIOLOGY | 1.52e-03 | 1432 | 34 | 10 | M509 | |
| Pathway | WP_NEURAL_CREST_DIFFERENTIATION | 1.62e-03 | 97 | 34 | 3 | MM15926 | |
| Pathway | PID_LYMPH_ANGIOGENESIS_PATHWAY | 1.64e-03 | 25 | 34 | 2 | M274 | |
| Pathway | REACTOME_BINDING_AND_UPTAKE_OF_LIGANDS_BY_SCAVENGER_RECEPTORS | 1.67e-03 | 98 | 34 | 3 | M27152 | |
| Pathway | WP_ANGIOTENSIN_II_RECEPTOR_TYPE_1_PATHWAY | 2.05e-03 | 28 | 34 | 2 | M42541 | |
| Pathway | REACTOME_LAMININ_INTERACTIONS | 2.35e-03 | 30 | 34 | 2 | M27216 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_OF_PLURIPOTENT_STEM_CELLS | 2.51e-03 | 31 | 34 | 2 | M27393 | |
| Pathway | WP_TYPE_I_COLLAGEN_SYNTHESIS_IN_THE_CONTEXT_OF_OSTEOGENESIS_IMPERFECTA | 2.84e-03 | 33 | 34 | 2 | M39870 | |
| Pathway | REACTOME_GPVI_MEDIATED_ACTIVATION_CASCADE | 3.20e-03 | 35 | 34 | 2 | MM14512 | |
| Pathway | REACTOME_GPVI_MEDIATED_ACTIVATION_CASCADE | 3.20e-03 | 35 | 34 | 2 | M773 | |
| Pathway | REACTOME_PLATELET_AGGREGATION_PLUG_FORMATION | 3.76e-03 | 38 | 34 | 2 | MM15456 | |
| Pathway | REACTOME_PLATELET_AGGREGATION_PLUG_FORMATION | 3.96e-03 | 39 | 34 | 2 | M10735 | |
| Pathway | PID_INTEGRIN3_PATHWAY | 4.79e-03 | 43 | 34 | 2 | M53 | |
| Pathway | REACTOME_VESICLE_MEDIATED_TRANSPORT | 7.09e-03 | 725 | 34 | 6 | M27507 | |
| Pathway | WP_NRP1TRIGGERED_SIGNALING_IN_PANCREATIC_CANCER | 7.47e-03 | 54 | 34 | 2 | M42568 | |
| Pathway | WP_PI3KAKT_SIGNALING | 8.63e-03 | 339 | 34 | 4 | M39736 | |
| Pathway | WP_PREIMPLANTATION_EMBRYO | 8.86e-03 | 59 | 34 | 2 | M39579 | |
| Pathway | WP_DEVELOPMENT_OF_URETERIC_COLLECTION_SYSTEM | 9.16e-03 | 60 | 34 | 2 | M40048 | |
| Pathway | PID_ENDOTHELIN_PATHWAY | 1.01e-02 | 63 | 34 | 2 | M8 | |
| Pathway | PID_IL4_2PATHWAY | 1.04e-02 | 64 | 34 | 2 | M28 | |
| Pubmed | COL2A1 COL3A1 COL18A1 COL7A1 COL11A1 IGFBP7 COL28A1 COL5A3 COL22A1 COL1A1 COL1A2 | 1.20e-15 | 175 | 50 | 11 | 28071719 | |
| Pubmed | Characterization of the Extracellular Matrix of Normal and Diseased Tissues Using Proteomics. | COL2A1 COL3A1 COL18A1 COL7A1 COL11A1 COL28A1 COL5A3 COL1A1 COL1A2 | 3.34e-13 | 135 | 50 | 9 | 28675934 |
| Pubmed | Glycoproteomics Reveals Decorin Peptides With Anti-Myostatin Activity in Human Atrial Fibrillation. | 1.33e-12 | 97 | 50 | 8 | 27559042 | |
| Pubmed | 3.78e-12 | 4 | 50 | 4 | 16537906 | ||
| Pubmed | Collagen II is essential for the removal of the notochord and the formation of intervertebral discs. | 1.48e-11 | 15 | 50 | 5 | 9832566 | |
| Pubmed | 1.89e-11 | 5 | 50 | 4 | 15365990 | ||
| Pubmed | ColVa1 and ColXIa1 are required for myocardial morphogenesis and heart valve development. | 5.66e-11 | 6 | 50 | 4 | 17029294 | |
| Pubmed | 5.66e-11 | 6 | 50 | 4 | 9101290 | ||
| Pubmed | 1.08e-10 | 167 | 50 | 8 | 22159717 | ||
| Pubmed | 2.60e-10 | 25 | 50 | 5 | 19180518 | ||
| Pubmed | The pro-alpha2(XI) collagen gene is expressed in odontoblasts. | 2.63e-10 | 8 | 50 | 4 | 20059976 | |
| Pubmed | 2.63e-10 | 8 | 50 | 4 | 9164858 | ||
| Pubmed | 2.63e-10 | 8 | 50 | 4 | 18816857 | ||
| Pubmed | A census of human transcription factors: function, expression and evolution. | MSX1 FOXD3 HOXD11 ESRRA SKOR2 BHLHE22 PITX1 ZBTB4 PBX1 PHOX2B PBX2 TAL1 CRAMP1 | 3.50e-10 | 908 | 50 | 13 | 19274049 |
| Pubmed | Proteomic characterization of human multiple myeloma bone marrow extracellular matrix. | 3.74e-10 | 62 | 50 | 6 | 28344315 | |
| Pubmed | Bone morphology is regulated modularly by global and regional genetic programs. | 4.74e-10 | 9 | 50 | 4 | 31221640 | |
| Pubmed | 4.74e-10 | 9 | 50 | 4 | 8900172 | ||
| Pubmed | 2.37e-09 | 153 | 50 | 7 | 25037231 | ||
| Pubmed | 2.77e-09 | 39 | 50 | 5 | 33580754 | ||
| Pubmed | 2.80e-09 | 3 | 50 | 3 | 23546968 | ||
| Pubmed | 2.80e-09 | 3 | 50 | 3 | 34205850 | ||
| Pubmed | Coordinate patterns of expression of type I and III collagens during mouse development. | 2.80e-09 | 3 | 50 | 3 | 8785585 | |
| Pubmed | Differential expression of type I and type III collagen genes during tooth development. | 2.80e-09 | 3 | 50 | 3 | 1879336 | |
| Pubmed | 2.80e-09 | 3 | 50 | 3 | 12200454 | ||
| Pubmed | 2.80e-09 | 3 | 50 | 3 | 17662583 | ||
| Pubmed | Distributions of types I, II and III collagen by region in the human supraspinatus tendon. | 2.80e-09 | 3 | 50 | 3 | 24088220 | |
| Pubmed | Mutations in collagen genes: causes of rare and some common diseases in humans. | 2.80e-09 | 3 | 50 | 3 | 2010058 | |
| Pubmed | Control of pelvic girdle development by genes of the Pbx family and Emx2. | 3.74e-09 | 14 | 50 | 4 | 21455939 | |
| Pubmed | 1.01e-08 | 50 | 50 | 5 | 23658023 | ||
| Pubmed | Localization of types I and III collagen and fibronectin in the developing mouse palatal shelves. | 1.12e-08 | 4 | 50 | 3 | 8984825 | |
| Pubmed | Immunohistochemical characteristics of developing mandibular angle in fetal mice. | 1.12e-08 | 4 | 50 | 3 | 16356873 | |
| Pubmed | 1.12e-08 | 4 | 50 | 3 | 9880238 | ||
| Pubmed | 1.12e-08 | 4 | 50 | 3 | 10633870 | ||
| Pubmed | 1.12e-08 | 4 | 50 | 3 | 19932771 | ||
| Pubmed | 1.12e-08 | 4 | 50 | 3 | 24361166 | ||
| Pubmed | 1.12e-08 | 4 | 50 | 3 | 1409674 | ||
| Pubmed | Specific hybridization probes for mouse type I, II, III and IX collagen mRNAs. | 1.12e-08 | 4 | 50 | 3 | 2054384 | |
| Pubmed | 1.12e-08 | 4 | 50 | 3 | 8686743 | ||
| Pubmed | 1.12e-08 | 4 | 50 | 3 | 1916105 | ||
| Pubmed | An orphan receptor tyrosine kinase family whose members serve as nonintegrin collagen receptors. | 2.79e-08 | 5 | 50 | 3 | 9659900 | |
| Pubmed | 2.79e-08 | 5 | 50 | 3 | 11973338 | ||
| Pubmed | Collagen and tenascin-C expression along the migration pathway of mouse primordial germ cells. | 2.79e-08 | 5 | 50 | 3 | 14758483 | |
| Pubmed | Extracellular matrix protein expression during mouse detrusor development. | 2.79e-08 | 5 | 50 | 3 | 12592609 | |
| Pubmed | 2.79e-08 | 5 | 50 | 3 | 19790048 | ||
| Pubmed | 3.93e-08 | 24 | 50 | 4 | 25344368 | ||
| Pubmed | Sox9 sustains chondrocyte survival and hypertrophy in part through Pik3ca-Akt pathways. | 5.52e-08 | 26 | 50 | 4 | 21367821 | |
| Pubmed | 5.57e-08 | 6 | 50 | 3 | 15514164 | ||
| Pubmed | Development and regeneration of the neonatal digit tip in mice. | 5.57e-08 | 6 | 50 | 3 | 18234177 | |
| Pubmed | Retarded skeletal development in transgenic mice with a type II collagen mutation. | 5.57e-08 | 6 | 50 | 3 | 8952549 | |
| Pubmed | 5.57e-08 | 6 | 50 | 3 | 21467034 | ||
| Pubmed | 5.57e-08 | 6 | 50 | 3 | 10722718 | ||
| Pubmed | 5.57e-08 | 6 | 50 | 3 | 17135260 | ||
| Pubmed | Developmental pattern of expression of the mouse alpha 1 (XI) collagen gene (Col11a1). | 5.57e-08 | 6 | 50 | 3 | 8563024 | |
| Pubmed | 5.57e-08 | 6 | 50 | 3 | 16556917 | ||
| Pubmed | Interaction of human thrombospondin with types I-V collagen: direct binding and electron microscopy. | 5.57e-08 | 6 | 50 | 3 | 3571333 | |
| Pubmed | The molecular chaperone Hsp47 is essential for cartilage and endochondral bone formation. | 5.57e-08 | 6 | 50 | 3 | 22492985 | |
| Pubmed | 6.47e-08 | 27 | 50 | 4 | 11566859 | ||
| Pubmed | Chondromodulin I is dispensable during enchondral ossification and eye development. | 6.47e-08 | 27 | 50 | 4 | 12192060 | |
| Pubmed | Crk and Crkl Are Required in the Endocardial Lineage for Heart Valve Development. | 6.51e-08 | 72 | 50 | 5 | 37702066 | |
| Pubmed | 6.74e-08 | 146 | 50 | 6 | 27068509 | ||
| Pubmed | Impact of cytosine methylation on DNA binding specificities of human transcription factors. | 7.43e-08 | 544 | 50 | 9 | 28473536 | |
| Pubmed | 9.75e-08 | 7 | 50 | 3 | 23273220 | ||
| Pubmed | 9.75e-08 | 7 | 50 | 3 | 10072783 | ||
| Pubmed | 1.56e-07 | 8 | 50 | 3 | 27664939 | ||
| Pubmed | Filamin B mutations cause chondrocyte defects in skeletal development. | 1.56e-07 | 8 | 50 | 3 | 17510210 | |
| Pubmed | Type XIII collagen strongly affects bone formation in transgenic mice. | 1.56e-07 | 8 | 50 | 3 | 16007336 | |
| Pubmed | 1.56e-07 | 8 | 50 | 3 | 15872058 | ||
| Pubmed | 1.56e-07 | 8 | 50 | 3 | 26553654 | ||
| Pubmed | 3D Mapping Reveals a Complex and Transient Interstitial Matrix During Murine Kidney Development. | 1.56e-07 | 8 | 50 | 3 | 33875569 | |
| Pubmed | Comprehensive proteomic characterization of stem cell-derived extracellular matrices. | 1.60e-07 | 86 | 50 | 5 | 28327460 | |
| Pubmed | Loss of ADAMTS19 causes progressive non-syndromic heart valve disease. | 2.33e-07 | 9 | 50 | 3 | 31844321 | |
| Pubmed | 2.33e-07 | 9 | 50 | 3 | 31199918 | ||
| Pubmed | 2.69e-07 | 38 | 50 | 4 | 25572963 | ||
| Pubmed | FOXL2 modulates cartilage, skeletal development and IGF1-dependent growth in mice. | 2.69e-07 | 38 | 50 | 4 | 26134413 | |
| Pubmed | Global defects in collagen secretion in a Mia3/TANGO1 knockout mouse. | 2.99e-07 | 39 | 50 | 4 | 21606205 | |
| Pubmed | 3.33e-07 | 10 | 50 | 3 | 30738849 | ||
| Pubmed | Development of heart valve leaflets and supporting apparatus in chicken and mouse embryos. | 3.33e-07 | 10 | 50 | 3 | 15162503 | |
| Pubmed | 3.33e-07 | 10 | 50 | 3 | 14559231 | ||
| Pubmed | Ucma is not necessary for normal development of the mouse skeleton. | 3.33e-07 | 10 | 50 | 3 | 22155508 | |
| Pubmed | 3.33e-07 | 10 | 50 | 3 | 20864640 | ||
| Pubmed | 3.33e-07 | 10 | 50 | 3 | 29797482 | ||
| Pubmed | 3.33e-07 | 10 | 50 | 3 | 2446864 | ||
| Pubmed | VEGF stimulates intramembranous bone formation during craniofacial skeletal development. | 3.33e-07 | 10 | 50 | 3 | 26899202 | |
| Pubmed | Involvement of endogenous bone morphogenetic protein (BMP) 2 and BMP6 in bone formation. | 3.33e-07 | 10 | 50 | 3 | 16109715 | |
| Pubmed | Hsp and chaperone distribution during endochondral bone development in mouse embryo. | 4.58e-07 | 11 | 50 | 3 | 9880236 | |
| Pubmed | 4.58e-07 | 11 | 50 | 3 | 2745554 | ||
| Pubmed | Binding of proteins to the PDZ domain regulates proteolytic activity of HtrA1 serine protease. | 4.58e-07 | 11 | 50 | 3 | 15101818 | |
| Pubmed | 4.58e-07 | 11 | 50 | 3 | 35988140 | ||
| Pubmed | 4.58e-07 | 11 | 50 | 3 | 24248941 | ||
| Pubmed | The Type 3 Deiodinase Is a Critical Modulator of Thyroid Hormone Sensitivity in the Fetal Brain. | 5.39e-07 | 45 | 50 | 4 | 34248495 | |
| Pubmed | 5.74e-07 | 210 | 50 | 6 | 16537572 | ||
| Pubmed | 6.09e-07 | 12 | 50 | 3 | 32002646 | ||
| Pubmed | Activation of Hypoxia Signaling in Stromal Progenitors Impairs Kidney Development. | 6.44e-07 | 47 | 50 | 4 | 28527294 | |
| Pubmed | 7.92e-07 | 13 | 50 | 3 | 25746793 | ||
| Pubmed | Ultrastructural cartilage abnormalities in MIA/CD-RAP-deficient mice. | 7.92e-07 | 13 | 50 | 3 | 11839810 | |
| Pubmed | 7.92e-07 | 13 | 50 | 3 | 31961823 | ||
| Pubmed | EGR1 and EGR2 involvement in vertebrate tendon differentiation. | 7.92e-07 | 13 | 50 | 3 | 21173153 | |
| Pubmed | 7.92e-07 | 13 | 50 | 3 | 19653325 | ||
| Pubmed | The Mohawk homeobox gene is a critical regulator of tendon differentiation. | 7.92e-07 | 13 | 50 | 3 | 20498044 | |
| Pubmed | 1.01e-06 | 14 | 50 | 3 | 30459452 | ||
| Interaction | SPARC interactions | 2.01e-10 | 65 | 49 | 7 | int:SPARC | |
| Interaction | THBS1 interactions | 6.23e-07 | 127 | 49 | 6 | int:THBS1 | |
| Interaction | BGN interactions | 8.07e-07 | 30 | 49 | 4 | int:BGN | |
| Interaction | PDGFA interactions | 1.05e-06 | 32 | 49 | 4 | int:PDGFA | |
| Interaction | MMP2 interactions | 2.19e-06 | 87 | 49 | 5 | int:MMP2 | |
| Interaction | LAIR2 interactions | 6.03e-06 | 49 | 49 | 4 | int:LAIR2 | |
| Interaction | FGF7 interactions | 7.40e-06 | 16 | 49 | 3 | int:FGF7 | |
| Interaction | PAX3 interactions | 7.66e-06 | 52 | 49 | 4 | int:PAX3 | |
| Interaction | COL1A1 interactions | 1.46e-05 | 128 | 49 | 5 | int:COL1A1 | |
| Interaction | MMP9 interactions | 2.11e-05 | 67 | 49 | 4 | int:MMP9 | |
| Interaction | TGFBI interactions | 2.99e-05 | 25 | 49 | 3 | int:TGFBI | |
| Interaction | COL1A2 interactions | 3.85e-05 | 78 | 49 | 4 | int:COL1A2 | |
| Interaction | MAG interactions | 4.72e-05 | 29 | 49 | 3 | int:MAG | |
| Interaction | PDGFB interactions | 6.19e-05 | 88 | 49 | 4 | int:PDGFB | |
| Interaction | VWF interactions | 6.38e-05 | 32 | 49 | 3 | int:VWF | |
| Interaction | SMAD3 interactions | 9.68e-05 | 447 | 49 | 7 | int:SMAD3 | |
| Interaction | RARB interactions | 1.91e-04 | 46 | 49 | 3 | int:RARB | |
| Interaction | C1QTNF1 interactions | 2.03e-04 | 47 | 49 | 3 | int:C1QTNF1 | |
| Interaction | COL4A1 interactions | 2.16e-04 | 48 | 49 | 3 | int:COL4A1 | |
| Interaction | COL5A3 interactions | 2.57e-04 | 10 | 49 | 2 | int:COL5A3 | |
| Interaction | MEIS1 interactions | 2.75e-04 | 52 | 49 | 3 | int:MEIS1 | |
| Interaction | HTRA1 interactions | 3.07e-04 | 54 | 49 | 3 | int:HTRA1 | |
| Interaction | PCOLCE interactions | 3.14e-04 | 11 | 49 | 2 | int:PCOLCE | |
| Interaction | SHOX interactions | 3.14e-04 | 11 | 49 | 2 | int:SHOX | |
| Interaction | LYL1 interactions | 4.44e-04 | 13 | 49 | 2 | int:LYL1 | |
| Interaction | FAM222A interactions | 4.44e-04 | 13 | 49 | 2 | int:FAM222A | |
| Interaction | SIN3B interactions | 4.46e-04 | 147 | 49 | 4 | int:SIN3B | |
| Cytoband | 2p23 | 1.56e-04 | 17 | 50 | 2 | 2p23 | |
| Cytoband | 19q13.1 | 1.66e-03 | 55 | 50 | 2 | 19q13.1 | |
| GeneFamily | Collagens | COL2A1 COL3A1 COL18A1 COL7A1 COL11A1 COL28A1 COL5A3 COL22A1 COL1A1 COL1A2 | 3.19e-18 | 46 | 40 | 10 | 490 |
| GeneFamily | TALE class homeoboxes and pseudogenes | 1.50e-03 | 26 | 40 | 2 | 526 | |
| Coexpression | NABA_COLLAGENS | COL2A1 COL3A1 COL18A1 COL7A1 COL11A1 COL28A1 COL5A3 COL22A1 COL1A1 COL1A2 | 4.47e-19 | 43 | 50 | 10 | MM17060 |
| Coexpression | NABA_COLLAGENS | COL2A1 COL3A1 COL18A1 COL7A1 COL11A1 COL28A1 COL5A3 COL22A1 COL1A1 COL1A2 | 5.77e-19 | 44 | 50 | 10 | M3005 |
| Coexpression | NABA_CORE_MATRISOME | COL2A1 COL3A1 COL18A1 COL7A1 COL11A1 IGFBP7 COL28A1 COL5A3 COL22A1 COL1A1 COL1A2 | 2.96e-12 | 270 | 50 | 11 | MM17057 |
| Coexpression | NABA_CORE_MATRISOME | COL2A1 COL3A1 COL18A1 COL7A1 COL11A1 IGFBP7 COL28A1 COL5A3 COL22A1 COL1A1 COL1A2 | 3.61e-12 | 275 | 50 | 11 | M5884 |
| Coexpression | HEBERT_MATRISOME_TNBC_BONE_METASTASIS | 3.83e-09 | 11 | 50 | 4 | M47997 | |
| Coexpression | HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION | 4.07e-09 | 200 | 50 | 8 | M5930 | |
| Coexpression | NABA_MATRISOME_PRIMARY_METASTATIC_LUNG_TUMOR | 6.39e-09 | 35 | 50 | 5 | MM17054 | |
| Coexpression | HAY_BONE_MARROW_STROMAL | COL3A1 FZD8 MSX1 COL7A1 COL11A1 IGFBP7 HOXD11 SAMD11 COL28A1 COL5A3 COL1A1 COL1A2 | 1.58e-08 | 767 | 50 | 12 | M39209 |
| Coexpression | ESC_V6.5_UP_EARLY.V1_DN | 2.52e-08 | 163 | 50 | 7 | M2769 | |
| Coexpression | NABA_MATRISOME_METASTATIC_LUNG_LYMPH_NODE_METASTASIS | 2.69e-07 | 29 | 50 | 4 | MM17055 | |
| Coexpression | NABA_MATRISOME | COL2A1 COL3A1 COL18A1 COL7A1 COL11A1 IGFBP7 NTF4 COL28A1 COL5A3 COL22A1 COL1A1 COL1A2 | 3.08e-07 | 1008 | 50 | 12 | MM17056 |
| Coexpression | NABA_MATRISOME | COL2A1 COL3A1 COL18A1 COL7A1 COL11A1 IGFBP7 NTF4 COL28A1 COL5A3 COL22A1 COL1A1 COL1A2 | 3.72e-07 | 1026 | 50 | 12 | M5889 |
| Coexpression | PILON_KLF1_TARGETS_UP | COL2A1 COL3A1 COL18A1 COL11A1 IGFBP7 PBX1 C2orf72 COL1A1 COL1A2 | 4.09e-07 | 503 | 50 | 9 | M2226 |
| Coexpression | BENPORATH_EED_TARGETS | COL2A1 FZD8 MSX1 FOXD3 IGFBP7 HOXD11 BHLHE22 PITX1 RFX6 PHOX2B RAB32 TAL1 | 5.21e-07 | 1059 | 50 | 12 | M7617 |
| Coexpression | PILON_KLF1_TARGETS_UP | COL2A1 COL3A1 COL18A1 COL11A1 IGFBP7 PBX1 C2orf72 COL1A1 COL1A2 | 7.51e-07 | 541 | 50 | 9 | MM1061 |
| Coexpression | TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_DUCTAL_NORMAL_UP | 1.97e-06 | 47 | 50 | 4 | M7585 | |
| Coexpression | AIZARANI_LIVER_C33_STELLATE_CELLS_2 | 4.22e-06 | 126 | 50 | 5 | M39132 | |
| Coexpression | THUM_MIR21_TARGETS_HEART_DISEASE_UP | 5.22e-06 | 18 | 50 | 3 | MM1241 | |
| Coexpression | THUM_MIR21_TARGETS_HEART_DISEASE_UP | 5.22e-06 | 18 | 50 | 3 | M13796 | |
| Coexpression | SENESE_HDAC2_TARGETS_DN | 5.50e-06 | 133 | 50 | 5 | M6906 | |
| Coexpression | ANASTASSIOU_MULTICANCER_INVASIVENESS_SIGNATURE | 6.84e-06 | 64 | 50 | 4 | M2572 | |
| Coexpression | DESCARTES_FETAL_HEART_SCHWANN_CELLS | 8.22e-06 | 67 | 50 | 4 | M40194 | |
| Coexpression | GOTZMANN_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_UP | 8.72e-06 | 68 | 50 | 4 | M1373 | |
| Coexpression | LEE_NEURAL_CREST_STEM_CELL_UP | 8.96e-06 | 147 | 50 | 5 | M2506 | |
| Coexpression | TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_DUCTAL_NORMAL_UP | 9.24e-06 | 69 | 50 | 4 | M10165 | |
| Coexpression | GOTZMANN_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_UP | 1.10e-05 | 72 | 50 | 4 | MM1131 | |
| Coexpression | TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_LOBULAR_NORMAL_UP | 1.22e-05 | 74 | 50 | 4 | M4479 | |
| Coexpression | TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_LOBULAR_NORMAL_DN | 1.22e-05 | 74 | 50 | 4 | M13547 | |
| Coexpression | MA_RAT_AGING_DN | 1.39e-05 | 161 | 50 | 5 | M46419 | |
| Coexpression | YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_16 | 1.58e-05 | 79 | 50 | 4 | M18400 | |
| Coexpression | YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_16 | 1.67e-05 | 80 | 50 | 4 | MM1285 | |
| Coexpression | MENON_FETAL_KIDNEY_3_STROMAL_CELLS | 1.75e-05 | 81 | 50 | 4 | M39253 | |
| Coexpression | MA_RAT_AGING_DN | 1.81e-05 | 170 | 50 | 5 | MM16097 | |
| Coexpression | DURANTE_ADULT_OLFACTORY_NEUROEPITHELIUM_FIBROBLASTS_STROMAL_CELLS | 1.84e-05 | 82 | 50 | 4 | M39274 | |
| Coexpression | KIM_GLIS2_TARGETS_UP | 2.22e-05 | 86 | 50 | 4 | M2259 | |
| Coexpression | NAKAMURA_CANCER_MICROENVIRONMENT_UP | 2.30e-05 | 29 | 50 | 3 | M7581 | |
| Coexpression | HUMMERICH_SKIN_CANCER_PROGRESSION_UP | 2.43e-05 | 88 | 50 | 4 | M1167 | |
| Coexpression | GRESHOCK_CANCER_COPY_NUMBER_UP | 3.37e-05 | 323 | 50 | 6 | M9150 | |
| Coexpression | DESCARTES_ORGANOGENESIS_LIMB_MESENCHYME | 3.42e-05 | 33 | 50 | 3 | MM3669 | |
| Coexpression | HEBERT_MATRISOME_TNBC_BONE_METASTASIS_TUMOR_CELL_DERIVED | 3.55e-05 | 5 | 50 | 2 | M47996 | |
| Coexpression | GSE339_CD8POS_VS_CD4CD8DN_DC_UP | 3.94e-05 | 200 | 50 | 5 | M5117 | |
| Coexpression | HUMMERICH_SKIN_CANCER_PROGRESSION_UP | 4.01e-05 | 100 | 50 | 4 | MM514 | |
| Coexpression | BENPORATH_ES_WITH_H3K27ME3 | COL2A1 MSX1 FOXD3 MAP6 SAMD11 BHLHE22 PITX1 RFX6 PHOX2B TAL1 | 4.05e-05 | 1115 | 50 | 10 | M10371 |
| Coexpression | MURARO_PANCREAS_MESENCHYMAL_STROMAL_CELL | 4.08e-05 | 681 | 50 | 8 | M39175 | |
| Coexpression | KIM_GLIS2_TARGETS_UP | 4.34e-05 | 102 | 50 | 4 | MM1064 | |
| Coexpression | GAO_LARGE_INTESTINE_ADULT_CJ_IMMUNE_CELLS | 4.61e-05 | 505 | 50 | 7 | M39167 | |
| Coexpression | HEBERT_MATRISOME_TNBC_LUNG_METASTASIS_TUMOR_CELL_DERIVED | 5.32e-05 | 6 | 50 | 2 | M48000 | |
| Coexpression | LEE_AGING_MUSCLE_DN | 6.14e-05 | 40 | 50 | 3 | M1574 | |
| Coexpression | FOROUTAN_INTEGRATED_TGFB_EMT_UP | 8.18e-05 | 120 | 50 | 4 | M42505 | |
| Coexpression | JONES_OVARY_THECA | 9.36e-05 | 46 | 50 | 3 | M48349 | |
| Coexpression | LEE_AGING_MUSCLE_DN | 9.36e-05 | 46 | 50 | 3 | MM670 | |
| Coexpression | CUI_DEVELOPING_HEART_SMOOTH_MUSCLE_CELL | 1.06e-04 | 48 | 50 | 3 | M39318 | |
| Coexpression | DESCARTES_FETAL_ADRENAL_SCHWANN_CELLS | 1.11e-04 | 130 | 50 | 4 | M40147 | |
| Coexpression | ROY_WOUND_BLOOD_VESSEL_UP | 1.20e-04 | 50 | 50 | 3 | M7337 | |
| Coexpression | BENPORATH_SUZ12_TARGETS | 1.31e-04 | 1035 | 50 | 9 | M9898 | |
| Coexpression | DESCARTES_FETAL_THYMUS_STROMAL_CELLS | 1.37e-04 | 137 | 50 | 4 | M40313 | |
| Coexpression | HALLMARK_UV_RESPONSE_DN | 1.65e-04 | 144 | 50 | 4 | M5942 | |
| Coexpression | IGLESIAS_E2F_TARGETS_UP | 1.65e-04 | 144 | 50 | 4 | M1484 | |
| Coexpression | DESCARTES_FETAL_KIDNEY_STROMAL_CELLS | 1.74e-04 | 146 | 50 | 4 | M40222 | |
| Coexpression | IGLESIAS_E2F_TARGETS_UP | 1.84e-04 | 148 | 50 | 4 | MM1010 | |
| Coexpression | CROMER_TUMORIGENESIS_UP | 1.87e-04 | 58 | 50 | 3 | M178 | |
| Coexpression | HU_FETAL_RETINA_BLOOD | 1.98e-04 | 282 | 50 | 5 | M39263 | |
| Coexpression | POMEROY_MEDULLOBLASTOMA_DESMOPLASIC_VS_CLASSIC_DN | 2.17e-04 | 61 | 50 | 3 | M8510 | |
| Coexpression | BENPORATH_PRC2_TARGETS | 2.21e-04 | 650 | 50 | 7 | M8448 | |
| Coexpression | RUIZ_TNC_TARGETS_UP | 2.25e-04 | 156 | 50 | 4 | M988 | |
| Coexpression | ACEVEDO_LIVER_CANCER_WITH_H3K27ME3_UP | 2.26e-04 | 290 | 50 | 5 | M11616 | |
| Coexpression | WILCOX_RESPONSE_TO_PROGESTERONE_DN | 2.28e-04 | 62 | 50 | 3 | M16774 | |
| Coexpression | MEBARKI_HCC_PROGENITOR_FZD8CRD_DN | 2.31e-04 | 459 | 50 | 6 | M38993 | |
| Coexpression | CARRILLOREIXACH_HEPATOBLASTOMA_VS_NORMAL_HYPOMETHYLATED_AND_UP | 2.59e-04 | 162 | 50 | 4 | M45037 | |
| Coexpression | CUI_DEVELOPING_HEART_COMPACT_VENTRICULAR_CARDIOMYOCYTE | 2.62e-04 | 65 | 50 | 3 | M39309 | |
| Coexpression | FAN_OVARY_CL6_PUTATIVE_EARLY_ATRETIC_FOLLICLE_THECAL_CELL_2 | 2.64e-04 | 300 | 50 | 5 | M41708 | |
| Coexpression | ZHONG_SECRETOME_OF_LUNG_CANCER_AND_ENDOTHELIUM | 2.87e-04 | 67 | 50 | 3 | M1686 | |
| Coexpression | ZHONG_SECRETOME_OF_LUNG_CANCER_AND_ENDOTHELIUM | 3.41e-04 | 71 | 50 | 3 | MM1210 | |
| Coexpression | FAN_OVARY_CL5_HEALTHY_SELECTABLE_FOLLICLE_THECAL_CELL | 3.45e-04 | 318 | 50 | 5 | M41707 | |
| Coexpression | LANDIS_BREAST_CANCER_PROGRESSION_DN | 3.55e-04 | 72 | 50 | 3 | M9908 | |
| Coexpression | TABULA_MURIS_SENIS_GONADAL_ADIPOSE_TISSUE_MYELOID_CELL_AGEING | 3.76e-04 | 324 | 50 | 5 | MM3701 | |
| Coexpression | RUBENSTEIN_SKELETAL_MUSCLE_FAP_CELLS | 3.79e-04 | 179 | 50 | 4 | M41745 | |
| Coexpression | PEREZ_TP53_TARGETS | 3.96e-04 | 1201 | 50 | 9 | M4391 | |
| Coexpression | LANDIS_BREAST_CANCER_PROGRESSION_DN | 4.00e-04 | 75 | 50 | 3 | MM1084 | |
| Coexpression | WONG_ADULT_TISSUE_STEM_MODULE | 4.13e-04 | 721 | 50 | 7 | M1999 | |
| Coexpression | DEMAGALHAES_AGING_DN | 4.21e-04 | 16 | 50 | 2 | M2145 | |
| Coexpression | TABULA_MURIS_SENIS_MESENTERIC_ADIPOSE_TISSUE_ENDOTHELIAL_CELL_AGEING | 4.66e-04 | 79 | 50 | 3 | MM3780 | |
| Coexpression | VANDESLUIS_COMMD1_TARGETS_GROUP_4_DN | 4.76e-04 | 17 | 50 | 2 | MM1301 | |
| Coexpression | VANDESLUIS_COMMD1_TARGETS_GROUP_4_DN | 4.76e-04 | 17 | 50 | 2 | M2302 | |
| Coexpression | FOROUTAN_TGFB_EMT_UP | 4.94e-04 | 192 | 50 | 4 | M42501 | |
| Coexpression | AIZARANI_LIVER_C21_STELLATE_CELLS_1 | 5.13e-04 | 194 | 50 | 4 | M39122 | |
| Coexpression | KANG_AR_TARGETS_DN | 5.35e-04 | 18 | 50 | 2 | MM892 | |
| Coexpression | KARAKAS_TGFB1_SIGNALING | 5.35e-04 | 18 | 50 | 2 | M17300 | |
| Coexpression | KANG_AR_TARGETS_DN | 5.35e-04 | 18 | 50 | 2 | M2225 | |
| Coexpression | SWEET_KRAS_TARGETS_UP | 5.39e-04 | 83 | 50 | 3 | M2448 | |
| Coexpression | BROWNE_HCMV_INFECTION_16HR_DN | 5.39e-04 | 83 | 50 | 3 | M19130 | |
| Coexpression | SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP | 5.48e-04 | 352 | 50 | 5 | M17471 | |
| Coexpression | ZHU_CMV_24_HR_DN | 5.58e-04 | 84 | 50 | 3 | M4065 | |
| Coexpression | GSE33374_CD8_ALPHAALPHA_VS_ALPHABETA_CD161_HIGH_TCELL_UP | 5.65e-04 | 199 | 50 | 4 | M8538 | |
| Coexpression | GSE2826_WT_VS_XID_BCELL_DN | 5.76e-04 | 200 | 50 | 4 | M4897 | |
| Coexpression | GSE29164_DAY3_VS_DAY7_CD8_TCELL_AND_IL12_TREATED_MELANOMA_DN | 5.76e-04 | 200 | 50 | 4 | M8490 | |
| Coexpression | FARMER_BREAST_CANCER_CLUSTER_4 | 5.97e-04 | 19 | 50 | 2 | M15125 | |
| Coexpression | HUMMERICH_MALIGNANT_SKIN_TUMOR_UP | 5.97e-04 | 19 | 50 | 2 | M1126 | |
| Coexpression | SHEPARD_BMYB_MORPHOLINO_DN | 5.98e-04 | 202 | 50 | 4 | M11840 | |
| Coexpression | NAKAYAMA_SOFT_TISSUE_TUMORS_PCA2_UP | 6.61e-04 | 89 | 50 | 3 | M2761 | |
| CoexpressionAtlas | Progenitor-Cell-Biology-Consortium_EmbryoidBody_top-relative-expression-ranked_500 | COL2A1 COL3A1 MSX1 COL11A1 MAP6 SAMD11 PITX1 PHOX2B TMEM200C C2orf72 COL1A1 COL1A2 | 7.51e-10 | 496 | 48 | 12 | PCBC_EB_500 |
| CoexpressionAtlas | Progenitor-Cell-Biology-Consortium_EmbryoidBody_from_inducedPluripotentialStemCells_derived from_from_fibroblast_top-relative-expression-ranked_500 | COL2A1 COL3A1 MSX1 COL11A1 MAP6 SAMD11 PITX1 TMEM200C C2orf72 COL1A1 COL1A2 | 1.07e-08 | 497 | 48 | 11 | PCBC_EB_fibroblast_500 |
| CoexpressionAtlas | Progenitor-Cell-Biology-Consortium_EmbryoidBody_from_inducedPluripotentialStemCells_derived from_from_fibroblast_top-relative-expression-ranked_1000 | COL2A1 COL3A1 MSX1 COL11A1 HOXD11 MAP6 SAMD11 PITX1 PHOX2B TMEM200C C2orf72 COL1A1 COL1A2 | 1.83e-07 | 986 | 48 | 13 | PCBC_EB_fibroblast_1000 |
| CoexpressionAtlas | Progenitor-Cell-Biology-Consortium_EmbryoidBody_fromBlastocyst-derived-humanEmbryonicStemCells_top-relative-expression-ranked_1000 | COL2A1 COL3A1 MSX1 COL11A1 HOXD11 MAP6 SAMD11 PITX1 PHOX2B TMEM200C C2orf72 COL1A1 COL1A2 | 1.96e-07 | 992 | 48 | 13 | PCBC_EB_blastocyst_1000 |
| CoexpressionAtlas | Progenitor-Cell-Biology-Consortium_EmbryoidBody_top-relative-expression-ranked_1000 | COL2A1 COL3A1 MSX1 COL11A1 HOXD11 MAP6 SAMD11 PITX1 PHOX2B TMEM200C C2orf72 COL1A1 COL1A2 | 2.01e-07 | 994 | 48 | 13 | PCBC_EB_1000 |
| CoexpressionAtlas | ratio_EmbryoidBody_vs_StemCell_top-relative-expression-ranked_2500_k-means-cluster#3 | COL2A1 COL3A1 MSX1 COL11A1 HOXD11 MAP6 SAMD11 BHLHE22 COL5A3 PHOX2B C2orf72 COL1A1 COL1A2 | 6.00e-07 | 1094 | 48 | 13 | ratio_EB_vs_SC_2500_K3 |
| CoexpressionAtlas | AravindRamakr_EmbryoidBody-LF_top-relative-expression-ranked_2500_k-means-cluster#2 | COL2A1 COL3A1 COL11A1 IGFBP7 MAP6 SAMD11 BHLHE22 COL5A3 PHOX2B C2orf72 COL1A1 COL1A2 | 9.52e-07 | 951 | 48 | 12 | Arv_EB-LF_2500_K2 |
| CoexpressionAtlas | Progenitor-Cell-Biology-Consortium_EmbryoidBody_fromBlastocyst-derived-humanEmbryonicStemCells_top-relative-expression-ranked_500 | COL2A1 COL3A1 MSX1 COL11A1 PITX1 TMEM200C C2orf72 COL1A1 COL1A2 | 1.44e-06 | 496 | 48 | 9 | PCBC_EB_blastocyst_500 |
| CoexpressionAtlas | ratio_EmbryoidBody_vs_StemCell_top-relative-expression-ranked_500 | COL3A1 MSX1 COL11A1 IGFBP7 SAMD11 PITX1 PHOX2B COL1A1 COL1A2 | 1.49e-06 | 498 | 48 | 9 | PCBC_ratio_EB_vs_SC_500 |
| CoexpressionAtlas | ratio_EmbryoidBody_vs_StemCell_top-relative-expression-ranked_1000 | COL2A1 COL3A1 MSX1 COL11A1 IGFBP7 MAP6 SAMD11 PITX1 PHOX2B C2orf72 COL1A1 COL1A2 | 1.51e-06 | 994 | 48 | 12 | PCBC_ratio_EB_vs_SC_1000 |
| CoexpressionAtlas | AravindRamakr_EmbryoidBody-LF_top-relative-expression-ranked_100 | 2.76e-06 | 98 | 48 | 5 | Arv_EB-LF_100 | |
| CoexpressionAtlas | ratio_EmbryoidBody_vs_StemCell_top-relative-expression-ranked_100 | 3.05e-06 | 100 | 48 | 5 | PCBC_ratio_EB_vs_SC_100 | |
| CoexpressionAtlas | JC_fibro_top-relative-expression-ranked_2500_k-means-cluster#5 | COL3A1 COL11A1 IGFBP7 HOXD11 MAP6 SAMD11 COL5A3 C2orf72 COL1A1 COL1A2 | 1.13e-05 | 814 | 48 | 10 | JC_fibro_2500_K5 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P2_bladder stroma (LCM)_emap-30396_k-means-cluster#3_top-relative-expression-ranked_1000 | 1.24e-05 | 229 | 48 | 6 | gudmap_developingLowerUrinaryTract_P2_bladder stroma (LCM)_1000_k3 | |
| CoexpressionAtlas | AravindRamakr_EmbryoidBody-LF_top-relative-expression-ranked_500 | 1.39e-05 | 496 | 48 | 8 | Arv_EB-LF_500 | |
| CoexpressionAtlas | BM Top 100 - endometrium | 1.49e-05 | 66 | 48 | 4 | BM Top 100 - endometrium | |
| CoexpressionAtlas | Ectoderm Differentiated Cells_vs_Pluripotent Stem Cells-Confounder_removed-fold2.0_adjp0.05 | COL2A1 MSX1 COL7A1 COL11A1 IGFBP7 ZBTB4 R3HDM2 COL22A1 ZNF579 HSD17B1 PBX2 RAB32 COL1A2 | 1.51e-05 | 1466 | 48 | 13 | PCBC_ratio_ECTO_vs_SC_cfr-2X-p05 |
| CoexpressionAtlas | ECTO blastocyst_vs_ECTO bone marrow-Confounder_removed-fold2.0_adjp0.05 | 1.75e-05 | 143 | 48 | 5 | PCBC_ratio_ECTO blastocyst_vs_ECTO bone marrow_cfr-2X-p05 | |
| CoexpressionAtlas | BM Top 100 - vagina | 2.62e-05 | 76 | 48 | 4 | BM Top 100 - vagina | |
| CoexpressionAtlas | ratio_EmbryoidBody_vs_StemCell_top-relative-expression-ranked_1000_k-means-cluster#5 | 3.88e-05 | 416 | 48 | 7 | ratio_EB_vs_SC_1000_K5 | |
| CoexpressionAtlas | Mesoderm Day 5-reprogram_OSKM-L_vs_Mesoderm Day 5-reprogram_NA-Confounder_removed-fold2.0_adjp0.05 | 3.92e-05 | 281 | 48 | 6 | PCBC_ratio_MESO-5_from-OSKM-L_vs_MESO-5_from-ESC_cfr-2X-p05 | |
| CoexpressionAtlas | Mesoderm Day 5-method_mRNA_vs_Mesoderm Day 5-method_NA-Confounder_removed-fold2.0_adjp0.05 | 3.92e-05 | 281 | 48 | 6 | PCBC_ratio_MESO-5_from-mRNA_vs_MESO-5_from-ESC_cfr-2X-p05 | |
| CoexpressionAtlas | Stromal Cells, St.31-38-44-.SLN, CD45- gp38- CD31- CD44-, Lymph Node, avg-2 | 4.07e-05 | 85 | 48 | 4 | GSM777067_100 | |
| CoexpressionAtlas | Stromal Cells, FRC.SLN, gp38+ CD31- CD140a+, Lymph Node, avg-4 | 4.26e-05 | 86 | 48 | 4 | GSM777055_100 | |
| CoexpressionAtlas | Stromal Cells, FRC.MLN, gp38+ CD31- CD140a+, Lymph Node, avg-5 | 4.46e-05 | 87 | 48 | 4 | GSM777050_100 | |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e9.5_MandibularArch_vs_MaxillaryArch_top-relative-expression-ranked_1000 | COL3A1 MSX1 COL7A1 IGFBP7 PITX1 ZBTB4 ZNF579 DRG1 COL1A1 COL1A2 | 4.94e-05 | 967 | 48 | 10 | Facebase_RNAseq_ratio_e9.5_MandibularArch_vs_MaxillaryArch_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_1000 | COL2A1 MSX1 COL7A1 IGFBP7 USP51 PITX1 ZBTB4 ZNF579 COL1A1 COL1A2 | 5.44e-05 | 978 | 48 | 10 | Facebase_RNAseq_e10.5_Mandibular Arch_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P2_bladder stroma (LCM)_emap-30396_top-relative-expression-ranked_1000 | COL3A1 IGFBP7 PITX1 ZBTB4 COL5A3 HSD17B1 PHOX2B COL1A1 COL1A2 | 5.55e-05 | 783 | 48 | 9 | gudmap_developingLowerUrinaryTract_P2_bladder stroma (LCM)_1000 |
| CoexpressionAtlas | AravindRamakr_EmbryoidBody-LF_top-relative-expression-ranked_1000 | COL2A1 COL3A1 COL11A1 SAMD11 PITX1 COL5A3 TMEM200C C2orf72 COL1A1 COL1A2 | 5.58e-05 | 981 | 48 | 10 | Arv_EB-LF_1000 |
| CoexpressionAtlas | JC_fibro_top-relative-expression-ranked_1000 | COL3A1 COL7A1 COL11A1 IGFBP7 HOXD11 SAMD11 PITX1 COL5A3 COL1A1 COL1A2 | 6.02e-05 | 990 | 48 | 10 | JC_fibro_1000 |
| CoexpressionAtlas | Stromal Cells, Fi.MTS15+.Th, CD45- PDGFRa+ MTS15+, Thymus, avg-3 | 6.82e-05 | 97 | 48 | 4 | GSM777043_100 | |
| CoexpressionAtlas | Stromal Cells, Fi.Sk, gp38+ CD140a+, Skin, avg-4 | 6.82e-05 | 97 | 48 | 4 | GSM777046_100 | |
| CoexpressionAtlas | Progenitor-Cell-Biology-Consortium_reference_CardiacMyocyte_top-relative-expression-ranked_100 | 7.39e-05 | 99 | 48 | 4 | PCBC_ctl_CardiacMyocyte_100 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_k-means-cluster#5_top-relative-expression-ranked_1000 | 8.09e-05 | 197 | 48 | 5 | gudmap_developingGonad_e16.5_epididymis_1000_k5 | |
| CoexpressionAtlas | Progenitor-Cell-Biology-Consortium_induced-Ectoderm_fromBlastocyst-derived-humanEmbryonicStemCells_top-relative-expression-ranked_500 | 1.04e-04 | 487 | 48 | 7 | PCBC_ECTO_blastocyst_500 | |
| CoexpressionAtlas | JC_fibro_top-relative-expression-ranked_500 | 1.14e-04 | 494 | 48 | 7 | JC_fibro_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_500_k-means-cluster#1 | 2.59e-04 | 137 | 48 | 4 | Facebase_RNAseq_e10.5_Mandibular Arch_500_K1 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Olfactory Pit_top-relative-expression-ranked_1000 | 3.12e-04 | 984 | 48 | 9 | Facebase_RNAseq_e10.5_Olfactory Pit_1000 | |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitTestis_Sma_top-relative-expression-ranked_1000 | 3.20e-04 | 777 | 48 | 8 | gudmap_dev gonad_e13.5_M_InterstitTestis_Sma_1000 | |
| CoexpressionAtlas | Myeloid Cells, DC.103+11b-.Lu, CD11chi CD11b low CD103+ MHCII+ SiglecF-, Lung, avg-3 | 3.69e-04 | 424 | 48 | 6 | GSM538231_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Olfactory Pit_top-relative-expression-ranked_1000_k-means-cluster#5 | 3.88e-04 | 276 | 48 | 5 | Facebase_RNAseq_e10.5_Olfactory Pit_1000_K5 | |
| CoexpressionAtlas | ratio_induced-Ectoderm_vs_StemCell_top-relative-expression-ranked_500_k-means-cluster#1 | 4.08e-04 | 279 | 48 | 5 | ratio_ECTO_vs_SC_500_K1 | |
| CoexpressionAtlas | AravindRamakr_EmbryoidBody-LF_top-relative-expression-ranked_1000_k-means-cluster#4 | 4.13e-04 | 433 | 48 | 6 | Arv_EB-LF_1000_K4 | |
| CoexpressionAtlas | BM Top 100 - myometrium | 4.29e-04 | 65 | 48 | 3 | BM Top 100 - myometrium | |
| CoexpressionAtlas | ECTO blastocyst_vs_ECTO UCB CD34+Z-Confounder_removed-fold2.0_adjp0.05 | 4.42e-04 | 284 | 48 | 5 | PCBC_ratio_ECTO blastocyst_vs_ECTO UCB CD34+Z_cfr-2X-p05 | |
| CoexpressionAtlas | dev lower uro neuro_e15.5_PelvicGanglion_Sox10_k-means-cluster#3_top-relative-expression-ranked_1000 | 4.49e-04 | 66 | 48 | 3 | gudmap_dev lower uro neuro_e15.5_PelvicGanglion_Sox10_k3_1000 | |
| CoexpressionAtlas | BM Top 100 - cervix | 4.49e-04 | 66 | 48 | 3 | BM Top 100 - cervix | |
| CoexpressionAtlas | BM Top 100 - colon cecum | 4.90e-04 | 68 | 48 | 3 | BM Top 100 - colon cecum | |
| CoexpressionAtlas | BM Top 100 - saphenous vein | 5.12e-04 | 69 | 48 | 3 | BM Top 100 - saphenous vein | |
| CoexpressionAtlas | BM Top 100 - ovary | 5.34e-04 | 70 | 48 | 3 | BM Top 100 - ovary | |
| CoexpressionAtlas | BM Top 100 - adipose tissue | 5.34e-04 | 70 | 48 | 3 | BM Top 100 - adipose tissue | |
| CoexpressionAtlas | BM Top 100 - dorsal root ganglia | 5.56e-04 | 71 | 48 | 3 | BM Top 100 - dorsal root ganglia | |
| CoexpressionAtlas | BM Top 100 - stomach fundus | 5.56e-04 | 71 | 48 | 3 | BM Top 100 - stomach fundus | |
| CoexpressionAtlas | BM Top 100 - adipose tissue subcutaneous | 5.79e-04 | 72 | 48 | 3 | BM Top 100 - adipose tissue subcutaneous | |
| CoexpressionAtlas | BM Top 100 - stomach cardiac | 5.79e-04 | 72 | 48 | 3 | BM Top 100 - stomach cardiac | |
| CoexpressionAtlas | DevelopingKidney_e11.5_metaneph mesench_emap-3843_top-relative-expression-ranked_1000 | 5.81e-04 | 850 | 48 | 8 | gudmap_developingKidney_e11.5_metaneph mesench_1000 | |
| CoexpressionAtlas | kidney single cell_e11.5_MetanephMesench_StemCellamp_top-relative-expression-ranked_1000 | 5.81e-04 | 646 | 48 | 7 | gudmap_kidney single cell_e11.5_MetanephMesench_Scamp_1000 | |
| CoexpressionAtlas | Ectoderm Differentiated Cells_vs_Endoderm Differentiated Cells-Confounder_removed-fold2.0_adjp0.05 | COL2A1 MSX1 COL7A1 COL11A1 IGFBP7 ZBTB4 COL22A1 HSD17B1 COL1A2 | 5.94e-04 | 1075 | 48 | 9 | PCBC_ratio_ECTO_vs_DE_cfr-2X-p05 |
| CoexpressionAtlas | JC_fibro_top-relative-expression-ranked_1000_k-means-cluster#1 | 5.95e-04 | 464 | 48 | 6 | JC_fibro_1000_K1 | |
| CoexpressionAtlas | BM Top 100 - coronary artery | 6.03e-04 | 73 | 48 | 3 | BM Top 100 - coronary artery | |
| CoexpressionAtlas | BM Top 100 - mammary gland | 6.28e-04 | 74 | 48 | 3 | BM Top 100 - mammary gland | |
| CoexpressionAtlas | BM Top 100 - adipose tissue omental | 6.28e-04 | 74 | 48 | 3 | BM Top 100 - adipose tissue omental | |
| CoexpressionAtlas | BM Top 100 - trigeminal ganglia | 6.53e-04 | 75 | 48 | 3 | BM Top 100 - trigeminal ganglia | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_k-means-cluster#4_top-relative-expression-ranked_500 | 6.54e-04 | 175 | 48 | 4 | gudmap_developingGonad_e14.5_ epididymis_500_k4 | |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e9.5_MandibularArch_vs_MaxillaryArch_top-relative-expression-ranked_500 | 7.02e-04 | 479 | 48 | 6 | Facebase_RNAseq_ratio_e9.5_MandibularArch_vs_MaxillaryArch_500 | |
| CoexpressionAtlas | BM Top 100 - urethra | 7.05e-04 | 77 | 48 | 3 | BM Top 100 - urethra | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Paraxial Mesoderm_top-relative-expression-ranked_500 | 7.82e-04 | 489 | 48 | 6 | Facebase_RNAseq_e8.5_Paraxial Mesoderm_500 | |
| CoexpressionAtlas | BM Top 100 - vulva | 8.47e-04 | 82 | 48 | 3 | BM Top 100 - vulva | |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitTestis_Sma_k-means-cluster#4_top-relative-expression-ranked_1000 | 9.06e-04 | 191 | 48 | 4 | gudmap_dev gonad_e12.5_M_InterstitTestis_Sma_k4_1000 | |
| CoexpressionAtlas | BM Top 100 - nipple cross-section | 9.08e-04 | 84 | 48 | 3 | BM Top 100 - nipple cross-section | |
| CoexpressionAtlas | Mesoderm Day 5_vs_Pluripotent Stem Cells-Confounder_removed-fold2.0_adjp0.05 | COL2A1 FZD8 COL18A1 COL11A1 SAMD11 ZBTB4 R3HDM2 ZNF579 RAB32 | 9.80e-04 | 1153 | 48 | 9 | PCBC_ratio_MESO-5_vs_SC_cfr-2X-p05 |
| CoexpressionAtlas | DevelopingGonad_e11.5_ovary + mesonephros_emap-3226_k-means-cluster#1_top-relative-expression-ranked_500 | 1.07e-03 | 89 | 48 | 3 | gudmap_developingGonad_e11.5_ovary + mesonephros_k1_500 | |
| CoexpressionAtlas | ratio_EmbryoidBody_vs_StemCell_top-relative-expression-ranked_500_k-means-cluster#3 | 1.16e-03 | 204 | 48 | 4 | ratio_EB_vs_SC_500_K3 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_k-means-cluster#1_top-relative-expression-ranked_500 | 1.18e-03 | 92 | 48 | 3 | gudmap_developingGonad_e16.5_epididymis_500_k1 | |
| CoexpressionAtlas | JC_fibro_top-relative-expression-ranked_500_k-means-cluster#3 | 1.20e-03 | 206 | 48 | 4 | JC_fibro_500_K3 | |
| CoexpressionAtlas | dev lower uro neuro_e15.5_PelvicGanglion_Sox10_top-relative-expression-ranked_1000 | 1.23e-03 | 734 | 48 | 7 | gudmap_dev lower uro neuro_e15.5_PelvicGanglion_Sox10_1000 | |
| CoexpressionAtlas | facebase_RNAseq_e14.5_palate_poster_nasal_Tgfbr2_WT_2500_K4 | 1.30e-03 | 95 | 48 | 3 | facebase_RNAseq_e14.5_palate_poster_nasal_Tgfbr2_WT_2500_K4 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Paraxial Mesoderm_top-relative-expression-ranked_1000 | 1.34e-03 | 967 | 48 | 8 | Facebase_RNAseq_e8.5_Paraxial Mesoderm_1000 | |
| CoexpressionAtlas | Ectoderm Differentiated Cells_vs_Mesoderm Day 5-Confounder_removed-fold2.0_adjp0.05 | 1.34e-03 | 967 | 48 | 8 | PCBC_ratio_ECTO_vs_MESO-5_cfr-2X-p05 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Maxillary Arch_top-relative-expression-ranked_1000 | 1.34e-03 | 967 | 48 | 8 | Facebase_RNAseq_e9.5_Maxillary Arch_1000 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Non-Floor Plate Neural Epithelium_top-relative-expression-ranked_1000 | 1.42e-03 | 976 | 48 | 8 | Facebase_RNAseq_e8.5_Non-Floor Plate Neural Epithelium_1000 | |
| CoexpressionAtlas | Progenitor-Cell-Biology-Consortium_induced-Ectoderm_fromBlastocyst-derived-humanEmbryonicStemCells_top-relative-expression-ranked_1000 | 1.42e-03 | 976 | 48 | 8 | PCBC_ECTO_blastocyst_1000 | |
| CoexpressionAtlas | JC_fibro_top-relative-expression-ranked_100 | 1.46e-03 | 99 | 48 | 3 | JC_fibro_100 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Maxillary Arch_top-relative-expression-ranked_1000_k-means-cluster#1 | 1.46e-03 | 371 | 48 | 5 | Facebase_RNAseq_e9.5_Maxillary Arch_1000_K1 | |
| CoexpressionAtlas | Mesoderm Day 15-method_episomal_vs_Mesoderm Day 15-method_NA-Confounder_removed-fold2.0_adjp0.05 | 1.50e-03 | 100 | 48 | 3 | PCBC_ratio_MESO-15_from-episomal_vs_MESO-15_from-ESC_cfr-2X-p05 | |
| CoexpressionAtlas | Mesoderm Day 15-reprogram_OSK-L-l-p53KD_vs_Mesoderm Day 15-reprogram_NA-Confounder_removed-fold2.0_adjp0.05 | 1.50e-03 | 100 | 48 | 3 | PCBC_ratio_MESO-15_from-OSK-L-l-p53KD_vs_MESO-15_from-ESC_cfr-2X-p05 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Olfactory Pit_top-relative-expression-ranked_2500_k-means-cluster#3 | 1.67e-03 | 567 | 48 | 6 | Facebase_RNAseq_e10.5_Olfactory Pit_2500_K3 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Olfactory Pit_top-relative-expression-ranked_500_k-means-cluster#1 | 1.68e-03 | 104 | 48 | 3 | Facebase_RNAseq_e10.5_Olfactory Pit_500_K1 | |
| CoexpressionAtlas | DevelopingKidney_e11.5_metaneph mesench_emap-3843_k-means-cluster#5_top-relative-expression-ranked_1000 | 2.19e-03 | 114 | 48 | 3 | gudmap_developingKidney_e11.5_metaneph mesench_1000_k5 | |
| CoexpressionAtlas | Mesoderm Day 15_vs_Mesoderm Day 5-Confounder_removed-fold2.0_adjp0.05 | 2.24e-03 | 1049 | 48 | 8 | PCBC_ratio_MESO-15_vs_MESO-5_cfr-2X-p05 | |
| CoexpressionAtlas | ratio_EmbryoidBody_vs_StemCell_top-relative-expression-ranked_500_k-means-cluster#5 | 2.30e-03 | 116 | 48 | 3 | ratio_EB_vs_SC_500_K5 | |
| CoexpressionAtlas | adrenal gland | 2.33e-03 | 247 | 48 | 4 | adrenal gland | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_top-relative-expression-ranked_500 | 2.34e-03 | 413 | 48 | 5 | gudmap_developingGonad_e14.5_ epididymis_500 | |
| CoexpressionAtlas | gudmap_RNAseq_e15.5_Mesangium_2500_K1 | 2.35e-03 | 117 | 48 | 3 | gudmap_RNAseq_e15.5_Mesangium_2500_K1 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Floor Plate_top-relative-expression-ranked_500_k-means-cluster#3 | 2.41e-03 | 118 | 48 | 3 | Facebase_RNAseq_e8.5_Floor Plate_500_K3 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_2500_k-means-cluster#3 | 2.54e-03 | 834 | 48 | 7 | Facebase_RNAseq_e10.5_Mandibular Arch_2500_K3 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-6668_top-relative-expression-ranked_500 | 2.57e-03 | 422 | 48 | 5 | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-6668_500 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e13.5_bladder mesenchyme_emap-3087_top-relative-expression-ranked_1000 | 2.59e-03 | 837 | 48 | 7 | gudmap_developingLowerUrinaryTract_e13.5_bladder mesenchyme_1000 | |
| CoexpressionAtlas | AravindRamakr_EmbryoidBody-LF_top-relative-expression-ranked_500_k-means-cluster#2 | 2.61e-03 | 255 | 48 | 4 | Arv_EB-LF_500_K2 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_k-means-cluster#4_top-relative-expression-ranked_1000 | 2.65e-03 | 256 | 48 | 4 | gudmap_developingGonad_e14.5_ epididymis_1000_k4 | |
| ToppCell | E17.5-Mesenchymal-mesenchymal_fibroblast-mesenchymal_alveolar_niche_cell|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 3.25e-11 | 185 | 50 | 8 | c85bba1210f1d389add3e40be9b96abac40cf8c1 | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-2M-Mesenchymal|Organoid-2M / Sample Type, Dataset, Time_group, and Cell type. | 4.75e-11 | 194 | 50 | 8 | 638b9fdce64ed00243b5303800ec66207d5fd640 | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-2M-Mesenchymal-choroid_plexus/mesenchymal-like_cells|Organoid-2M / Sample Type, Dataset, Time_group, and Cell type. | 4.75e-11 | 194 | 50 | 8 | e9868c22934b6c0ac35e3e8270ec0b671bc6582a | |
| ToppCell | nucseq-Mesenchymal-Myocytic|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 4.75e-11 | 194 | 50 | 8 | 2d66091097e106c7bee22e5281f50724700bdf8d | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.37e-11 | 197 | 50 | 8 | 236a40eb6c08e1d179cf0fb5450b032975c5f6b6 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-SMC_COL-F|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.59e-11 | 198 | 50 | 8 | eb78b2ae6a787dbc75947e8dd5a03693285bc8be | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-SMC_COL|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.59e-11 | 198 | 50 | 8 | 8b9e8eaeffda40912a0163fdf39b93bc5e64751c | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Neuronal-Glial_immature-Glia_2_(ELN+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.59e-11 | 198 | 50 | 8 | 52ddc1f1ed4ac4c3bac794c90b8feb03e3c221c4 | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Mesenchymal-fibroblastic-Stromal_1_(CCL11+)|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.59e-11 | 198 | 50 | 8 | 0f4052a59c6bd89dab637d6ef1214460d6cbcf55 | |
| ToppCell | facs-Limb_Muscle-forelimb_and_hindlimb-18m-Mesenchymal-mesenchymal_stem_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.87e-10 | 165 | 50 | 7 | f80665b75d43f1bf6919d59fc762e7e0bac653f2 | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Neuronal-Glial_immature-Glia_2_(ELN+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.79e-10 | 168 | 50 | 7 | 95dc690c1987b05685d36e6bb20eb79308696e30 | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Neuronal-Glial_immature-Glia_2_(ELN+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.79e-10 | 168 | 50 | 7 | af82e07d1eec51fc6530155f37addbce6221885d | |
| ToppCell | 3'-Child09-12-SmallIntestine-Mesenchymal-fibroblastic-Stromal_4_(MMP1+)|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.12e-09 | 177 | 50 | 7 | ac90e4ce5be304a5a7473736397327010f2d1999 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Neuronal-Glial_immature-Glia_2_(ELN+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.31e-09 | 181 | 50 | 7 | 098dbb3e0ff531c9720a233123250c1e39a97d4c | |
| ToppCell | PND14-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_mature|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.31e-09 | 181 | 50 | 7 | 6730e249cac55ae892cc567d9211615882f3dab4 | |
| ToppCell | PND14-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.31e-09 | 181 | 50 | 7 | 3462aa1c08fbaf613b6278ab2c7a5a0940bf537d | |
| ToppCell | PCW_07-8.5-Neuronal-Neuronal_SCP-neuro_pre_proliferating_SCP_(4)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.36e-09 | 182 | 50 | 7 | bfb725fff3d20066d8ac0a6ba2f88498fcbd876e | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Mesenchymal-podocyte|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.53e-09 | 185 | 50 | 7 | ca69499ba8c39b7ed6717d05685d6f70066a77bd | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts-Peribronchial_fibroblasts_L.2.1.3.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.53e-09 | 185 | 50 | 7 | 87c416d14ca6255bee39b16e7571553e36ee3069 | |
| ToppCell | Mesenchymal-chondrocyte|World / Lineage, Cell type, age group and donor | 1.71e-09 | 188 | 50 | 7 | 7b1e3f8a941eaa68e89c562129a92314642eec66 | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_mature|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.90e-09 | 191 | 50 | 7 | 75d2197076a9dfc868e8baf95bd4c5e44f438e3e | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_mature|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.98e-09 | 192 | 50 | 7 | 19b94f254d51b9bda3d9b7c6f85e27ecb58409c8 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_2_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.05e-09 | 193 | 50 | 7 | 9ab47b360bee1d4f1092c2269e58acebe9584021 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-Pericyte-C|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.28e-09 | 196 | 50 | 7 | 12d9028f90c057c6e5cff00301793fa550e86c5a | |
| ToppCell | metastatic_Brain-Fibroblasts|metastatic_Brain / Location, Cell class and cell subclass | 2.53e-09 | 199 | 50 | 7 | 63eb2106bb6e2e33d020628583536c8d96662c84 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Vascular-Mural_cell-SMC_prolif-A|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.38e-08 | 158 | 50 | 6 | 32c95c1bc9e50fccd6d06e828f29258fc5e568cb | |
| ToppCell | Hippocampus-Endothelial-ENDOTHELIAL_TIP-Dcn_1|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 2.48e-08 | 159 | 50 | 6 | 92049a8d8fc9997d8d0d76500c72596a9b2394e0 | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_prolif|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.69e-08 | 170 | 50 | 6 | 8465c3069bbc08705d070927e712b6bc85ac7c5b | |
| ToppCell | 3'-Child04-06-SmallIntestine-Mesenchymal-fibroblastic-mLTo|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.69e-08 | 170 | 50 | 6 | 7653f1205d4e62abe7e31b1d76f9bbd665e45667 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-Pericyte-B|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.82e-08 | 171 | 50 | 6 | a4a2c5dc995589fbe3d4ca6ee1df888807e4ae34 | |
| ToppCell | P07-Epithelial-epithelial_progenitor_cell-epithelial_unknown_3|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 3.95e-08 | 172 | 50 | 6 | 8d6a2a0d5f63b09a5a304a77e600a647f87e9de4 | |
| ToppCell | 5'-Airway_Nasal-Mesenchymal-Fibroblastic|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.18e-08 | 180 | 50 | 6 | 935c091bbcd6d10b81dc4731779e5bd98205c99f | |
| ToppCell | 5'-Adult-SmallIntestine-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.18e-08 | 180 | 50 | 6 | f2f6e83127a4a415e65c76a35efa8175fbd5b5d9 | |
| ToppCell | 5'-Airway_Nasal-Mesenchymal|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.18e-08 | 180 | 50 | 6 | 3dd384b7f3d9582b8fec9fe05100e466e6218b76 | |
| ToppCell | facs-Lung-3m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l17|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.18e-08 | 180 | 50 | 6 | 39ae8586efd91536e9ac6408d26de7e6d6237c41 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Vascular-Mural_cell-SMC_prolif|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.18e-08 | 180 | 50 | 6 | 64956a85c404a2ea7e4eaf6f95ebcc52c198b7cc | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Mesenchymal-fibroblastic-mLTo|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.18e-08 | 180 | 50 | 6 | d1c52aeceb3627e3c5fb6cc3af77e0400f9380ab | |
| ToppCell | PCW_10-12-Neuronal-Neuronal_postreplicative|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 5.35e-08 | 181 | 50 | 6 | 1aebb62ed4439db444ee9d30688212b86ee3d9ef | |
| ToppCell | PCW_10-12-Neuronal-Neuronal_postreplicative-neuro_NA|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 5.35e-08 | 181 | 50 | 6 | 6aee2ddee4790250ef3b2ef0038bd9839925c995 | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Neuronal-Glial_immature-Glia_2_(ELN+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.35e-08 | 181 | 50 | 6 | a436e7e4c36403257ea90160a58ca0d6d7c0cdfc | |
| ToppCell | PCW_10-12-Neuronal|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 5.35e-08 | 181 | 50 | 6 | 381b553e2cae65ce6be100662a5f9f963353840c | |
| ToppCell | wk_15-18-Epithelial-PNS-Late_Schwann|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 5.53e-08 | 182 | 50 | 6 | 6462e0469224457e249d10e224082f727caa02d6 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Vascular-Mural_cell-Pericyte-A|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.53e-08 | 182 | 50 | 6 | fc4a5bf784705efe7965ce43ac23c2a8e602e90a | |
| ToppCell | 5'-Airway_Nasal-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts-Peribronchial_fibroblasts_L.2.1.3.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.71e-08 | 183 | 50 | 6 | 6d98973098c6d20c5305bce6a83a549a7d8dbfba | |
| ToppCell | 5'-Airway_Nasal-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.71e-08 | 183 | 50 | 6 | cc7f5a17b40e8d901885174922e5fa8877643071 | |
| ToppCell | 5'-Airway_Nasal-Mesenchymal-Fibroblastic-fibroblastic_type_2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.71e-08 | 183 | 50 | 6 | 803376f5260de83c48d4f7301278d078a32b3e6e | |
| ToppCell | P07-Mesenchymal-mesenchymal_fibroblast-mesenchymal_alveolar_niche_cell|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 5.90e-08 | 184 | 50 | 6 | 01257e5c12e38b849fd3d9496c43ded666249ba5 | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_2_cell-D122|Adult / Lineage, Cell type, age group and donor | 5.90e-08 | 184 | 50 | 6 | 2b7e6f91e11c228f0521e099886867d9e998e78d | |
| ToppCell | P03-Epithelial-epithelial_progenitor_cell-epithelial_unknown_3|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 5.90e-08 | 184 | 50 | 6 | 8880ff36c243cc60a524d74934d000aef26a70ac | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Mesenchymal-Stroma____fibroblast|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.09e-08 | 185 | 50 | 6 | 785c55d39909fac74415f24427979691e7e694e6 | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Mesenchymal|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.09e-08 | 185 | 50 | 6 | 97a1dcacbc48dc3f41c26fbb59af35c935f894d4 | |
| ToppCell | 3'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.49e-08 | 187 | 50 | 6 | 6f47a80e612b320f571210483e62ff5db2a8ea43 | |
| ToppCell | 3'-Adult-LargeIntestine-Mesenchymal-stromal_related-T_reticular|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.49e-08 | 187 | 50 | 6 | f0c4d93f75615e570e4465fd622e3124189618a1 | |
| ToppCell | 3'-Adult-LargeIntestine-Mesenchymal-stromal_related|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.49e-08 | 187 | 50 | 6 | 3ff57da09ed8394913fb683669d7bff84a936623 | |
| ToppCell | droplet-Lung-LUNG-30m-Mesenchymal|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.49e-08 | 187 | 50 | 6 | 976b74d081b7fba8620768613cc26f9262cd7b16 | |
| ToppCell | TCGA-Colorectal-Primary_Tumor-Colorectal_Adenocarcinoma-Colon_Adenocarcinoma-7|TCGA-Colorectal / Sample_Type by Project: Shred V9 | 6.70e-08 | 188 | 50 | 6 | 14bc73cf79c79c9f208369fd8d498e5b26e0114d | |
| ToppCell | Pericytes-SSc-ILD_02|World / lung cells shred on cell class, cell subclass, sample id | 6.70e-08 | 188 | 50 | 6 | f16ff998393bf1954bbf10caab15173bdb104ac1 | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Neuronal|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.70e-08 | 188 | 50 | 6 | ccd2541892112a7a303f766adf9a7afeb754498c | |
| ToppCell | MatrixFB-Fibroblast-C|MatrixFB / shred on cell class and cell subclass (v4) | 7.14e-08 | 190 | 50 | 6 | d0106f7a21292f0b96ce4337ec3efbb1bd78dd0a | |
| ToppCell | droplet-Mammary_Gland-nan-3m-Mesenchymal|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.14e-08 | 190 | 50 | 6 | bd0d68dc1b6f388190a6ba8a83b011619abe2bdd | |
| ToppCell | droplet-Mammary_Gland-nan-3m-Mesenchymal-stromal_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.14e-08 | 190 | 50 | 6 | e275de94468872e70cf305b3b450823d4c9c5e3f | |
| ToppCell | droplet-Kidney-nan-3m-Mesenchymal|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.14e-08 | 190 | 50 | 6 | 2abeb013bb83c578e67dcb985ba44ca63134950b | |
| ToppCell | 3'-Adult-LargeIntestine-Mesenchymal-myocytic-myofibroblast|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.14e-08 | 190 | 50 | 6 | 591310e615700321a010a4b90405cbbbbdb3aade | |
| ToppCell | wk_08-11-Epithelial-PNS-Early_Schwann|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 7.14e-08 | 190 | 50 | 6 | 8190674a48607984726974765aafbca116f437e0 | |
| ToppCell | droplet-Mammary_Gland-nan-3m-Mesenchymal-stromal_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.14e-08 | 190 | 50 | 6 | ee2f4a55d2fd18b83e55399b5b5697a15a2d2e70 | |
| ToppCell | 10x5'v1-week_14-16-Myeloid_macrophage-stroma-erythroid_macrophage|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 7.14e-08 | 190 | 50 | 6 | cf463b2f227f3cc7d3fd296c810c0cbe51cbee72 | |
| ToppCell | TCGA-Ovary-Primary_Tumor-Ovarian_Carcinoma-Serous_Cystadenocarcinoma-3|TCGA-Ovary / Sample_Type by Project: Shred V9 | 7.36e-08 | 191 | 50 | 6 | 80d30d8eedb4c70b58440646325bc04c5700803e | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.36e-08 | 191 | 50 | 6 | 0fae1c2ef9f83ac7721d0a9d69455bf97eed9257 | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.36e-08 | 191 | 50 | 6 | 9f478f36a0b895e607e3bb77fa0f9f03cc0f33fc | |
| ToppCell | metastatic_Lymph_Node-Fibroblasts-Myofibroblasts|metastatic_Lymph_Node / Location, Cell class and cell subclass | 7.36e-08 | 191 | 50 | 6 | aa43b472bc8362f79ae63f09f1ca764718bbf22c | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.36e-08 | 191 | 50 | 6 | 4b50fdd310701251e64e16cd2d07ce03dbfd3e3e | |
| ToppCell | E15.5-Mesenchymal-mesenchymal_fibroblast-mesenchymal_alveolar_niche_cell|E15.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 7.36e-08 | 191 | 50 | 6 | 053b3664f509baa107feaf90730f80ebf9ac8f14 | |
| ToppCell | droplet-Kidney-nan-3m-Mesenchymal-Stroma____fibroblast|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.36e-08 | 191 | 50 | 6 | d1205aab0937f2becfcd239610e9b78fb8a0c886 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Vascular-Mural_cell-Pericyte|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 7.59e-08 | 192 | 50 | 6 | 09cb5b89a164ac7444774ccc8c90323c8ea2026b | |
| ToppCell | COVID-19-Heart-Fib_+_EC_+_Pericyte|Heart / Disease (COVID-19 only), tissue and cell type | 7.59e-08 | 192 | 50 | 6 | 60b1312e84f6d6448365a952469c506c00b5fe93 | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.59e-08 | 192 | 50 | 6 | ad48c941a3ddfd9a5146bafc2209da577bb50531 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_2_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 7.59e-08 | 192 | 50 | 6 | e0f4e4470a71bfa81d9dcd8594e5f82aafc24f81 | |
| ToppCell | PND28-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.59e-08 | 192 | 50 | 6 | cdc652dbfabe41b324fd85c1ed933d29fb73a49f | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Mesenchymal-immature_mesenchymal_cell-Mesoderm_2_(ZEB2+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.59e-08 | 192 | 50 | 6 | f053b89bfd6048c227667ff01c38df7c51d8a496 | |
| ToppCell | droplet-Limb_Muscle-Pre-Sort-18m-Mesenchymal-chondrocyte-like|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.59e-08 | 192 | 50 | 6 | b35f0e422070ba9c7c1d9ff3eace4edc10286cde | |
| ToppCell | PND28-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_mature|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.59e-08 | 192 | 50 | 6 | 29bee88b45e23f16543ffc7cc361bc5da5d16a2b | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_2_cell|Adult / Lineage, Cell type, age group and donor | 7.59e-08 | 192 | 50 | 6 | d21f0f577156f17c899b08871046a26b88aea011 | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-myocytic|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.83e-08 | 193 | 50 | 6 | 146e8c148478ab61b1c1dbaf1ee98a8cd4a0ff8a | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Vascular-Mural_cell|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 7.83e-08 | 193 | 50 | 6 | dd4bac8a93a5b9dcf7301f1d7d6e3eb6670f5c68 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Vascular|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 7.83e-08 | 193 | 50 | 6 | 2ddf9b2770a0be9689e01d1a3d19e4a6d42c7a50 | |
| ToppCell | nucseq-Mesenchymal-Myocytic-Myocytic_2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 7.83e-08 | 193 | 50 | 6 | 5de87fc94a6e58899ef4124cf4887ed3ff96163a | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_mature|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.83e-08 | 193 | 50 | 6 | 051f61156b0e2e95292b2d8377faf3190b50f264 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Vascular-Mural_cell-SMC_prolif-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 8.07e-08 | 194 | 50 | 6 | 78dcb9d48259afabe73b41c5508a73a8d62339a4 | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-4M-Mesenchymal|Organoid-4M / Sample Type, Dataset, Time_group, and Cell type. | 8.07e-08 | 194 | 50 | 6 | 4bafe26573cb2ff966f4a688c5769da598eea415 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-SMC_prolif-F|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 8.07e-08 | 194 | 50 | 6 | a7731378f44ca1a229311686caf5740c742d21ba | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-4M-Mesenchymal-choroid_plexus/mesenchymal-like_cells|Organoid-4M / Sample Type, Dataset, Time_group, and Cell type. | 8.07e-08 | 194 | 50 | 6 | 8ac0b63c7a89e5ff78bbdd8dd1960aa2422a85f7 | |
| ToppCell | Control-Stromal-Myofibroblast|Control / Disease state, Lineage and Cell class | 8.32e-08 | 195 | 50 | 6 | ffcf76cd72e43d8cf1058a49c76e0956065038bc | |
| ToppCell | Mesenchymal_cells-Stromal_fibro.|World / Lineage and Cell class | 8.32e-08 | 195 | 50 | 6 | 69723b06c2a5c2aaf4d10874b11bca7f06822bdc | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-SMC_COL-D|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 8.32e-08 | 195 | 50 | 6 | 78cfde21dde4b877fc76c8b0d5ddaabe44b912d7 | |
| ToppCell | 3'-Broncho-tracheal-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts-Peribronchial_fibroblasts_L.2.1.3.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.32e-08 | 195 | 50 | 6 | 51db90e7611f7d69980878c046505ff34212079b | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 8.58e-08 | 196 | 50 | 6 | 40e6900a0d56088a40d37ec312f53207ea952602 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_2_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 8.58e-08 | 196 | 50 | 6 | 525d6c8a277364e624e7cc586275f8a891436b57 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Vascular-Mural_cell-Scavenging_pericyte|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 8.58e-08 | 196 | 50 | 6 | cb61757646653f89faba503cb5d99e5dd5197b4c | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-Pericyte|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 8.58e-08 | 196 | 50 | 6 | 7acd782a587b7d331517f60daa8b5c2177bedfc7 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Mesenchymal-immature_mesenchymal_cell|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.58e-08 | 196 | 50 | 6 | cbfe01ba8071864e19b37028236ae35789f630fe | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 9.03e-06 | 50 | 29 | 4 | GAVISH_3CA_MALIGNANT_METAPROGRAM_12_EMT_1 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 9.03e-06 | 50 | 29 | 4 | GAVISH_3CA_METAPROGRAM_FIBROBLASTS_CAF_1 | |
| Computational | Adhesion molecules. | 3.33e-05 | 141 | 29 | 5 | MODULE_122 | |
| Computational | Neighborhood of CDH11 | 3.90e-05 | 25 | 29 | 3 | GNF2_CDH11 | |
| Computational | Neighborhood of PTX3 | 1.19e-04 | 36 | 29 | 3 | GNF2_PTX3 | |
| Computational | ECM and collagens. | 3.03e-04 | 225 | 29 | 5 | MODULE_47 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 3.18e-04 | 50 | 29 | 3 | GAVISH_3CA_METAPROGRAM_FIBROBLASTS_CAF_2 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 3.18e-04 | 50 | 29 | 3 | GAVISH_3CA_METAPROGRAM_EPITHELIAL_EMT_LIKE_1 | |
| Computational | Bone remodeling. | 3.99e-04 | 54 | 29 | 3 | MODULE_234 | |
| Computational | Genes in the cancer module 55. | 1.23e-03 | 832 | 29 | 8 | MODULE_55 | |
| Computational | Placenta genes. | 1.26e-03 | 463 | 29 | 6 | MODULE_38 | |
| Computational | Developmental processes. | 1.78e-03 | 333 | 29 | 5 | MODULE_220 | |
| Drug | GK-101 | 7.29e-15 | 36 | 49 | 8 | CID000161853 | |
| Drug | Madecassol | 6.19e-14 | 46 | 49 | 8 | CID000108062 | |
| Drug | d-indobufen | 1.27e-13 | 50 | 49 | 8 | CID000044562 | |
| Drug | ridogrel | 1.77e-13 | 52 | 49 | 8 | CID005362391 | |
| Drug | NSC49633 | 2.08e-13 | 53 | 49 | 8 | CID000023340 | |
| Drug | AC1LAKND | 7.82e-13 | 62 | 49 | 8 | CID000470146 | |
| Drug | BAPN | 2.42e-12 | 71 | 49 | 8 | CID000001647 | |
| Drug | malotilate | 2.42e-12 | 71 | 49 | 8 | CID000004006 | |
| Drug | L-3,4-dehydroproline | 3.05e-12 | 73 | 49 | 8 | CID000094284 | |
| Drug | AC1NMZ1B | 3.82e-12 | 75 | 49 | 8 | CID005034185 | |
| Drug | strontium ranelate | 4.75e-12 | 77 | 49 | 8 | CID006918182 | |
| Drug | DMSe | COL2A1 COL3A1 COL18A1 COL7A1 COL11A1 COL5A3 COL22A1 COL1A1 COL1A2 | 9.48e-12 | 132 | 49 | 9 | CID000020796 |
| Drug | halofuginone lactate | 1.07e-11 | 85 | 49 | 8 | CID000062891 | |
| Drug | 4-hydroxyproline | 1.88e-11 | 91 | 49 | 8 | CID000000825 | |
| Drug | Collagenase | 1.89e-11 | 4 | 49 | 4 | DB00048 | |
| Drug | ticlopidine | 5.15e-11 | 103 | 49 | 8 | CID000005472 | |
| Drug | hydroxylysine | 8.15e-11 | 109 | 49 | 8 | CID000001029 | |
| Drug | AC1L1C2F | 8.77e-11 | 110 | 49 | 8 | CID000001711 | |
| Drug | PPACK | 1.09e-10 | 113 | 49 | 8 | CID003036757 | |
| Drug | AC1L9732 | 1.17e-10 | 114 | 49 | 8 | CID000439300 | |
| Drug | Tranilast sodium | 1.26e-10 | 115 | 49 | 8 | CID000005527 | |
| Drug | Selara | 2.46e-10 | 125 | 49 | 8 | CID000150310 | |
| Drug | BPAT-143 | 2.83e-10 | 6 | 49 | 4 | CID000146249 | |
| Drug | pirfenidone | 5.43e-10 | 138 | 49 | 8 | CID000040632 | |
| Drug | DL-penicillamine | 5.75e-10 | 139 | 49 | 8 | CID000004727 | |
| Drug | PCR 4099 | 5.75e-10 | 139 | 49 | 8 | CID000002806 | |
| Drug | candesartan cilexetil | 8.06e-10 | 145 | 49 | 8 | CID000002540 | |
| Drug | AC1Q6PCP | COL2A1 COL3A1 COL18A1 COL7A1 COL11A1 ESRRA COL22A1 COL1A1 COL1A2 | 1.35e-09 | 230 | 49 | 9 | CID000005267 |
| Drug | L-lysyl-L-lysyl-L-lysine | 1.94e-09 | 162 | 49 | 8 | CID000072363 | |
| Drug | prostacyclin sodium salt | COL2A1 COL3A1 COL18A1 COL7A1 COL11A1 IGFBP7 COL22A1 COL1A1 COL1A2 | 2.82e-09 | 250 | 49 | 9 | CID000000159 |
| Drug | khellin | 2.98e-09 | 171 | 49 | 8 | CID000003828 | |
| Drug | AC1L1DD6 | 4.27e-09 | 179 | 49 | 8 | CID000002299 | |
| Drug | 4-aminoazobenzene | 5.96e-09 | 66 | 49 | 6 | CID000006051 | |
| Drug | 12(S)-hydroxyeicosatetraenoic acid | 6.55e-09 | 189 | 49 | 8 | CID000001413 | |
| Drug | foscarnet | 6.83e-09 | 190 | 49 | 8 | CID000003414 | |
| Drug | isodesmosine | 8.49e-09 | 33 | 49 | 5 | CID000013811 | |
| Drug | (2s,5s)-5-Carboxymethylproline | COL2A1 COL3A1 COL18A1 COL7A1 COL11A1 PITX1 COL22A1 COL1A1 COL1A2 | 2.04e-08 | 314 | 49 | 9 | CID000447989 |
| Drug | ascorbate-2-phosphate | 2.54e-08 | 15 | 49 | 4 | ctd:C011669 | |
| Drug | AC1L18QD | COL2A1 COL3A1 COL18A1 COL7A1 COL11A1 NTF4 COL22A1 COL1A1 COL1A2 | 2.74e-08 | 325 | 49 | 9 | CID000000213 |
| Drug | hyaluronan | 8.53e-08 | 263 | 49 | 8 | CID000024759 | |
| Drug | 351A | 8.94e-08 | 20 | 49 | 4 | CID000122144 | |
| Drug | desmosine | 9.94e-08 | 53 | 49 | 5 | CID000025435 | |
| Drug | silibinin | 1.58e-07 | 285 | 49 | 8 | CID000005213 | |
| Drug | Diphosphonates | 1.86e-07 | 6 | 49 | 3 | ctd:D004164 | |
| Drug | 2-phenyl-4-(3-pyridin-2-yl-1H-pyrazol-4-yl)pyridine | 1.86e-07 | 6 | 49 | 3 | ctd:C502971 | |
| Drug | AC1L1KMJ | COL2A1 COL3A1 COL18A1 COL7A1 COL11A1 PITX1 COL22A1 COL1A1 COL1A2 | 6.92e-07 | 476 | 49 | 9 | CID000030956 |
| Drug | losartan | 1.33e-06 | 378 | 49 | 8 | CID000003961 | |
| Drug | colchine | 1.47e-06 | 383 | 49 | 8 | CID000002833 | |
| Drug | 1-Naphthylisothiocyanate | COL3A1 FZD8 COL18A1 IGFBP7 SAMD11 ZBTB4 R3HDM2 RAB32 DNMT3A COL1A1 COL1A2 | 1.85e-06 | 871 | 49 | 11 | ctd:D015058 |
| Drug | PD123177 | 2.20e-06 | 43 | 49 | 4 | CID000114899 | |
| Drug | pyridinoline | 2.30e-06 | 99 | 49 | 5 | CID000105068 | |
| Drug | NC-4 | 2.41e-06 | 44 | 49 | 4 | CID006420119 | |
| Drug | chondroitin sulfate | 2.58e-06 | 413 | 49 | 8 | CID000024766 | |
| Drug | AC1L9N61 | 2.67e-06 | 102 | 49 | 5 | CID000449471 | |
| Drug | aspirin | COL2A1 COL3A1 COL18A1 COL7A1 COL11A1 PITX1 COL22A1 COL1A1 COL1A2 | 2.76e-06 | 563 | 49 | 9 | CID000002244 |
| Drug | chlorpromazine hydrochloride; Up 200; 1uM; HL60; HT_HG-U133A | 3.76e-06 | 195 | 49 | 6 | 6176_UP | |
| Drug | MRK 003 | COL2A1 FZD8 COL18A1 COL11A1 IGFBP7 COL5A3 ARMCX4 PBX1 RAB32 COL1A2 | 4.09e-06 | 760 | 49 | 10 | ctd:C523799 |
| Drug | Y-27632 | 4.39e-06 | 444 | 49 | 8 | CID000005711 | |
| Drug | 5'-methylthioadenosine | 4.54e-06 | 2 | 49 | 2 | ctd:C008500 | |
| Drug | tributyltin | 6.17e-06 | 465 | 49 | 8 | ctd:C011559 | |
| Drug | 1h00 | 6.40e-06 | 56 | 49 | 4 | CID000445950 | |
| Drug | morin hydrate | 6.88e-06 | 57 | 49 | 4 | CID003365422 | |
| Drug | pyrachlostrobin | MSX1 COL18A1 COL11A1 CEBPA IGFBP7 COL5A3 COL22A1 RAB32 KCNT1 COL1A1 | 7.25e-06 | 811 | 49 | 10 | ctd:C513428 |
| Drug | Acetaldehyde | 7.71e-06 | 221 | 49 | 6 | ctd:D000079 | |
| Drug | LMWH | COL2A1 COL3A1 COL18A1 COL7A1 COL11A1 IGFBP7 COL22A1 COL1A1 COL1A2 | 1.03e-05 | 663 | 49 | 9 | CID000000772 |
| Drug | selenomethylselenocysteine | 2.40e-05 | 78 | 49 | 4 | ctd:C002979 | |
| Drug | NSC19448 | 2.55e-05 | 273 | 49 | 6 | CID000003054 | |
| Drug | 9,10-epoxy-12-octadecenoic acid | 2.71e-05 | 4 | 49 | 2 | ctd:C051208 | |
| Drug | diacetylrhein | 2.71e-05 | 4 | 49 | 2 | ctd:C025292 | |
| Drug | 9,10-dihydroxy-12-octadecenoic acid | 2.71e-05 | 4 | 49 | 2 | ctd:C120038 | |
| Drug | ATFP | 2.71e-05 | 4 | 49 | 2 | CID000193783 | |
| Drug | AC1L1G2K | 3.22e-05 | 84 | 49 | 4 | CID000003498 | |
| Drug | paricalcitol | 3.70e-05 | 87 | 49 | 4 | ctd:C084656 | |
| Drug | (1S,2R)-1-amino-1-thiazolidin-2-yl-propan-2-ol | 4.22e-05 | 90 | 49 | 4 | CID015942693 | |
| Drug | Saralasin | 4.52e-05 | 5 | 49 | 2 | ctd:D012504 | |
| Drug | hydroxyoctadecadienoic acid | 4.52e-05 | 5 | 49 | 2 | ctd:C495366 | |
| Drug | D3273 | 5.01e-05 | 94 | 49 | 4 | CID005464587 | |
| Drug | cyanogen-bromide | 5.35e-05 | 34 | 49 | 3 | CID000010476 | |
| Drug | ICI 182,780; Down 200; 0.01uM; PC3; HT_HG-U133A | 5.71e-05 | 192 | 49 | 5 | 4462_DN | |
| Drug | PB-4 | 5.84e-05 | 35 | 49 | 3 | CID005289110 | |
| Drug | Sirius red | 5.84e-05 | 35 | 49 | 3 | CID005486818 | |
| Drug | Norgestrel-(-)-D [797-63-7]; Up 200; 12.8uM; PC3; HT_HG-U133A | 5.85e-05 | 193 | 49 | 5 | 3708_UP | |
| Drug | Sulfamethazine sodium salt [1981-58-4]; Up 200; 13.4uM; PC3; HT_HG-U133A | 5.85e-05 | 193 | 49 | 5 | 4322_UP | |
| Drug | deoxypyridinoline | 5.89e-05 | 98 | 49 | 4 | CID000105071 | |
| Drug | Methapyrilene hydrochloride [135-23-9]; Up 200; 13.4uM; PC3; HT_HG-U133A | 6.00e-05 | 194 | 49 | 5 | 6644_UP | |
| Drug | Flumethasone [2135-17-3]; Up 200; 9.8uM; MCF7; HT_HG-U133A | 6.00e-05 | 194 | 49 | 5 | 3610_UP | |
| Drug | 2-propylpentanoic acid; Up 200; 200uM; PC3; HT_HG-U133A | 6.15e-05 | 195 | 49 | 5 | 1214_UP | |
| Drug | Dioxybenzone [131-53-3]; Down 200; 16.4uM; MCF7; HT_HG-U133A | 6.61e-05 | 198 | 49 | 5 | 5699_DN | |
| Drug | Folinic acid calcium salt [6035-45-6]; Up 200; 7.8uM; PC3; HT_HG-U133A | 6.61e-05 | 198 | 49 | 5 | 3703_UP | |
| Drug | AG-H-50319 | 6.77e-05 | 6 | 49 | 2 | CID011819195 | |
| Drug | AC1L3XKP | 6.91e-05 | 37 | 49 | 3 | CID000123931 | |
| Drug | AC1MRIIV | 8.11e-05 | 39 | 49 | 3 | CID003518584 | |
| Drug | AC1NDTNH | 9.06e-05 | 343 | 49 | 6 | CID004631409 | |
| Drug | ammonium perchlorate | 9.46e-05 | 7 | 49 | 2 | ctd:C053506 | |
| Drug | neo-gambogic acid | 9.46e-05 | 7 | 49 | 2 | ctd:C045863 | |
| Drug | Oi-1 | 9.46e-05 | 7 | 49 | 2 | CID000448053 | |
| Drug | N-methylmesoporphyrin | 1.01e-04 | 42 | 49 | 3 | CID000444708 | |
| Drug | SC 560 | 1.09e-04 | 43 | 49 | 3 | ctd:C115461 | |
| Drug | Alstonine hydrochloride | 1.14e-04 | 116 | 49 | 4 | CID000023039 | |
| Drug | HHMD | 1.26e-04 | 8 | 49 | 2 | CID000171068 | |
| Disease | Familial thoracic aortic aneurysm and aortic dissection | 2.00e-08 | 53 | 46 | 5 | C4707243 | |
| Disease | Ehlers-Danlos Syndrome | 3.54e-08 | 5 | 46 | 3 | C0013720 | |
| Disease | osteogenesis imperfecta type 3 (is_implicated_in) | 2.38e-06 | 2 | 46 | 2 | DOID:0110339 (is_implicated_in) | |
| Disease | EHLERS-DANLOS SYNDROME, ARTHROCHALASIA TYPE | 2.38e-06 | 2 | 46 | 2 | C0268345 | |
| Disease | EHLERS-DANLOS SYNDROME, ARTHROCHALASIA TYPE, 1 | 2.38e-06 | 2 | 46 | 2 | C4551623 | |
| Disease | osteogenesis imperfecta type 4 (is_implicated_in) | 2.38e-06 | 2 | 46 | 2 | DOID:0110340 (is_implicated_in) | |
| Disease | osteogenesis imperfecta type 2 (is_implicated_in) | 2.38e-06 | 2 | 46 | 2 | DOID:0110341 (is_implicated_in) | |
| Disease | OSTEOGENESIS IMPERFECTA, TYPE IV | 2.38e-06 | 2 | 46 | 2 | 166220 | |
| Disease | Osteogenesis imperfecta with normal sclerae, dominant form | 2.38e-06 | 2 | 46 | 2 | cv:C0268363 | |
| Disease | Osteogenesis imperfecta type III | 2.38e-06 | 2 | 46 | 2 | cv:C0268362 | |
| Disease | OSTEOGENESIS IMPERFECTA, TYPE II | 2.38e-06 | 2 | 46 | 2 | 166210 | |
| Disease | Osteogenesis imperfecta, perinatal lethal | 2.38e-06 | 2 | 46 | 2 | cv:C0268358 | |
| Disease | OSTEOGENESIS IMPERFECTA, TYPE III | 2.38e-06 | 2 | 46 | 2 | 259420 | |
| Disease | Liver Cirrhosis, Experimental | 2.59e-06 | 774 | 46 | 9 | C0023893 | |
| Disease | osteogenesis imperfecta (is_implicated_in) | 7.13e-06 | 3 | 46 | 2 | DOID:12347 (is_implicated_in) | |
| Disease | osteogenesis imperfecta type 3 (implicated_via_orthology) | 7.13e-06 | 3 | 46 | 2 | DOID:0110339 (implicated_via_orthology) | |
| Disease | Heart valve disease | 8.99e-06 | 26 | 46 | 3 | C0018824 | |
| Disease | OSTEOPOROSIS | 1.42e-05 | 4 | 46 | 2 | 166710 | |
| Disease | Stickler syndrome, type 1 | 2.37e-05 | 5 | 46 | 2 | C2020284 | |
| Disease | Stickler syndrome | 2.37e-05 | 5 | 46 | 2 | cv:C0265253 | |
| Disease | Osteogenesis imperfecta, dominant perinatal lethal | 2.37e-05 | 5 | 46 | 2 | C0268358 | |
| Disease | osteogenesis imperfecta (implicated_via_orthology) | 2.37e-05 | 5 | 46 | 2 | DOID:12347 (implicated_via_orthology) | |
| Disease | Lobstein Disease | 2.37e-05 | 5 | 46 | 2 | C0023931 | |
| Disease | Osteoporosis | 3.55e-05 | 6 | 46 | 2 | cv:C0029456 | |
| Disease | Ehlers-Danlos syndrome (implicated_via_orthology) | 3.55e-05 | 6 | 46 | 2 | DOID:13359 (implicated_via_orthology) | |
| Disease | Fibrosis | 6.60e-05 | 50 | 46 | 3 | C0016059 | |
| Disease | Cirrhosis | 6.60e-05 | 50 | 46 | 3 | C1623038 | |
| Disease | Ehlers-Danlos syndrome | 6.62e-05 | 8 | 46 | 2 | cv:C0013720 | |
| Disease | bladder neck obstruction (biomarker_via_orthology) | 8.50e-05 | 9 | 46 | 2 | DOID:13948 (biomarker_via_orthology) | |
| Disease | Ehlers-Danlos syndrome (is_implicated_in) | 8.50e-05 | 9 | 46 | 2 | DOID:13359 (is_implicated_in) | |
| Disease | Craniofacial Abnormalities | 1.03e-04 | 156 | 46 | 4 | C0376634 | |
| Disease | Osteogenesis imperfecta type IV (disorder) | 1.06e-04 | 10 | 46 | 2 | C0268363 | |
| Disease | Nephrosclerosis | 1.30e-04 | 11 | 46 | 2 | C0027719 | |
| Disease | Retinal Detachment | 1.30e-04 | 11 | 46 | 2 | C0035305 | |
| Disease | Aortic Valve Insufficiency | 1.30e-04 | 11 | 46 | 2 | C0003504 | |
| Disease | Osteogenesis imperfecta type III (disorder) | 1.30e-04 | 11 | 46 | 2 | C0268362 | |
| Disease | intracranial aneurysm (is_implicated_in) | 1.55e-04 | 12 | 46 | 2 | DOID:10941 (is_implicated_in) | |
| Disease | rheumatic heart disease (biomarker_via_orthology) | 1.55e-04 | 12 | 46 | 2 | DOID:0050827 (biomarker_via_orthology) | |
| Disease | cleft palate (is_implicated_in) | 1.55e-04 | 12 | 46 | 2 | DOID:674 (is_implicated_in) | |
| Disease | Osteogenesis Imperfecta | 1.83e-04 | 13 | 46 | 2 | C0029434 | |
| Disease | Disproportionate short stature | 2.39e-04 | 77 | 46 | 3 | C0878659 | |
| Disease | osteoarthritis (implicated_via_orthology) | 2.46e-04 | 15 | 46 | 2 | DOID:8398 (implicated_via_orthology) | |
| Disease | Cleft Palate | 2.78e-04 | 81 | 46 | 3 | C0008925 | |
| Disease | Schwartz-Jampel Syndrome, Type 1 | 2.81e-04 | 16 | 46 | 2 | C4551479 | |
| Disease | Spondyloepiphyseal Dysplasia | 2.81e-04 | 16 | 46 | 2 | C0038015 | |
| Disease | Schwartz-Jampel Syndrome | 2.81e-04 | 16 | 46 | 2 | C0036391 | |
| Disease | Melnick-Needles Syndrome | 2.81e-04 | 16 | 46 | 2 | C0025237 | |
| Disease | Spondyloepiphyseal Dysplasia Tarda, X-Linked | 2.81e-04 | 16 | 46 | 2 | C3541456 | |
| Disease | Van Buchem disease | 3.19e-04 | 17 | 46 | 2 | C0432272 | |
| Disease | Acute myeloid leukemia | 3.19e-04 | 17 | 46 | 2 | cv:C0023467 | |
| Disease | LEUKEMIA, ACUTE MYELOID | 3.19e-04 | 17 | 46 | 2 | 601626 | |
| Disease | Oral Submucous Fibrosis | 3.58e-04 | 18 | 46 | 2 | C0029172 | |
| Disease | Dyschondroplasias | 4.00e-04 | 19 | 46 | 2 | C0013366 | |
| Disease | Osteochondrodysplasias | 4.00e-04 | 19 | 46 | 2 | C0029422 | |
| Disease | glaucoma (is_marker_for) | 4.44e-04 | 20 | 46 | 2 | DOID:1686 (is_marker_for) | |
| Disease | Multiple Epiphyseal Dysplasia | 4.44e-04 | 20 | 46 | 2 | C0026760 | |
| Disease | Osteogenesis imperfecta | 4.90e-04 | 21 | 46 | 2 | cv:C0029434 | |
| Disease | Liver Cirrhosis | 5.62e-04 | 103 | 46 | 3 | C0023890 | |
| Disease | Fibrosis, Liver | 5.95e-04 | 105 | 46 | 3 | C0239946 | |
| Disease | Early Pregnancy Loss | 6.63e-04 | 109 | 46 | 3 | C3830362 | |
| Disease | Miscarriage | 6.63e-04 | 109 | 46 | 3 | C4552766 | |
| Disease | Spontaneous abortion | 6.63e-04 | 109 | 46 | 3 | C0000786 | |
| Disease | Abortion, Tubal | 6.63e-04 | 109 | 46 | 3 | C0000822 | |
| Disease | Left Ventricular Hypertrophy | 6.97e-04 | 25 | 46 | 2 | C0149721 | |
| Disease | Acute monocytic leukemia | 7.55e-04 | 26 | 46 | 2 | C0023465 | |
| Disease | osteoporosis (is_implicated_in) | 1.07e-03 | 31 | 46 | 2 | DOID:11476 (is_implicated_in) | |
| Disease | Cholestasis, Extrahepatic | 1.14e-03 | 32 | 46 | 2 | C0005398 | |
| Disease | Mammary Carcinoma, Human | 1.31e-03 | 525 | 46 | 5 | C4704874 | |
| Disease | Mammary Neoplasms, Human | 1.31e-03 | 525 | 46 | 5 | C1257931 | |
| Disease | Mammary Neoplasms | 1.34e-03 | 527 | 46 | 5 | C1458155 | |
| Disease | Mental Retardation, Psychosocial | 1.34e-03 | 139 | 46 | 3 | C0025363 | |
| Disease | Profound Mental Retardation | 1.34e-03 | 139 | 46 | 3 | C0020796 | |
| Disease | Mental deficiency | 1.34e-03 | 139 | 46 | 3 | C0917816 | |
| Disease | retinal detachment, retinal break | 1.37e-03 | 35 | 46 | 2 | EFO_0005773, EFO_0010698 | |
| Disease | Keloid | 1.37e-03 | 35 | 46 | 2 | C0022548 | |
| Disease | Breast Carcinoma | 1.46e-03 | 538 | 46 | 5 | C0678222 | |
| Disease | Cataract | 1.53e-03 | 37 | 46 | 2 | C0086543 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| PGAAKPGGAAAEGAG | 61 | A6NCS6 | |
| PAGGQKGGAPAEGEG | 106 | Q9Y6K1 | |
| PGAGGGGAKAAEGCS | 171 | Q8NFJ8 | |
| GAGAVDQAGGCSKPG | 1561 | Q5H9R4 | |
| DGAKGEAGAPGVKGE | 296 | P02458 | |
| KDAQGLPGGGGGDNS | 901 | Q9Y2K5 | |
| CKADNAEEGGPGAGG | 141 | P34130 | |
| MAGGGAGDPGLGAAA | 1 | Q13637 | |
| GQPGGEQGGGEKGED | 51 | Q8HWS3 | |
| GVAGPEKGGGSAAAA | 116 | P40424 | |
| GVAGPEKGGGSAAAA | 126 | P40425 | |
| EAAPGGAGGLAAGKA | 216 | Q96JE9 | |
| GGPGEGFDVAKTGDA | 51 | Q9Y295 | |
| SEPGGCAKDAALGGG | 496 | H3BQL2 | |
| SEGKAGPGGAPAGAA | 11 | Q5JUK3 | |
| GSVGGVGEKGEPGEA | 1246 | P12107 | |
| GGSGGGAGGERPKEA | 276 | O14782 | |
| GDAGQKGERGEPGGG | 1331 | P39060 | |
| AGGGGAGPGGACKAE | 46 | Q1KMD3 | |
| FVLKNLGGPGDGGAG | 2116 | Q9UMN6 | |
| GKAGAAAGGPGVSGV | 96 | Q16270 | |
| EKVACSGGAPGAGGA | 336 | Q9H461 | |
| AGPAGAAGQPGAKGE | 726 | P08123 | |
| GVPGEDGAAGKKGEA | 516 | Q2UY09 | |
| DGAAGKKGEAGLPGA | 521 | Q2UY09 | |
| AKAAVGPTGGGGGGD | 91 | P49715 | |
| KAEAGAEAGGGAGPG | 291 | P14061 | |
| NAGGSGPRGKGAEGG | 106 | Q96RY5 | |
| NGPKAEGRGGSGGDS | 196 | O95886 | |
| GAADKGDPRTGAGGG | 206 | P31277 | |
| GSEPKGAAEGSGGDG | 231 | P31277 | |
| GAKGQEGAHGAPGAA | 901 | Q8NFW1 | |
| GAAAIAGIGGEKAGG | 1201 | P02461 | |
| GGLAGDLVGEPGAKG | 2316 | Q02388 | |
| GEGAGPGEQGGGKLV | 56 | P11474 | |
| GDIGEKGDSGPSGAA | 1226 | P25940 | |
| VGAPEADGCKGGVGG | 96 | Q9UJU5 | |
| GSGEGPGKAGSEGLQ | 381 | Q8WZA9 | |
| GAGGTGCGGADDPAK | 71 | P78337 | |
| LKPGGCGGSGDAFGA | 261 | A6NKL6 | |
| VEDSAFGKPAGGGAG | 16 | P28360 | |
| GGGPAGGGGAARDLK | 61 | P17542 | |
| VGGGGAAGDKGPGEA | 6 | Q9NV56 | |
| AGGAGAEGKGLFPGS | 491 | Q96NU1 | |
| PGGGVSGGKAEAEAA | 11 | O95081 | |
| AVGPAGKDGEAGAQG | 606 | P02452 | |
| GAPGNDGAKGDAGAP | 701 | P02452 | |
| DGAKGDAGAPGAPGS | 706 | P02452 | |
| AGEKGSPGADGPAGA | 931 | P02452 | |
| GGGGASPEEAVEKAG | 21 | Q70EK9 | |
| GKSGSEGPVGAGEGD | 891 | Q9P1Z0 | |
| GGGEAGGKEPAADAA | 26 | Q9UKN8 | |
| GAGAGGAGAAPKAGL | 436 | Q2VWA4 | |
| GPGGEPGKGGAAAAA | 231 | Q99453 | |
| AKGPEGGEGAECGGA | 346 | Q8NAF0 |